===== DISCHARGE NOTE =====
note_id=13874311-DS-20 | hadm_id=20254481

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___.
 
Chief Complaint:
Shortness of breath 

 
Major Surgical or Invasive Procedure:
None 

 
History of Present Illness:
___ F with PMHx of HTN, HLD, obseity s/p gastric bypass, 
anemia, and ESRD on peritoneal dialysis presented to ___ 
emergency department with increasing weakness over the past ___s shortness of breath.
.
Patient reports that 2 weeks ago she has noticed SOB with 
exertion, ie walking to the bathroom, dressing herself, climbing 
stairs. Feels like she cannot catch her breath. She also has 
associated palpitations in the ___ her chest that does not 
radiate. The patient does not have associated chest pain, 
abdominal pain, or diaphoresis. Patient reports 3 episodes of 
emesis over the weekend. She also feels lightheadedness 
associated with these episodes while walking to the bathroom. 
She denies falls or passing out. Of note, the patient noted that 
prior to the onset of her symptoms of SOB, she stopped urinating 
3 days prior (prebiously patient would make a small amount of 
urine despite PD). 
.
She reports a poor appetite for the past 1 month and a weight 
loss of 4 pounds. She denies weight gain, swelling in her ___ 
bilaterally. 
.
On the day of presentation, the patient was walking to her 
bathroom at home when she had the same onset of symptoms- she 
felt SOB, had chest palpitations, and dizziness. The patient had 
to be supported by her husband. Her next-door neighbor was 
called who is a nurse and assessed her. The patient's neighbor 
was unable to get a pulse and reportedly had a low BP. EMS was 
called and the patient was taken to ___.    
.
At the OSH ED, patient was noted to have an elevated white count 
with left shift. Her chest x-ray there was unremarkable and BNP 
was mildly elevated. Creatinine was elevated from her baseline, 
and so she was transferred to ___ ED for further work-up. A 
peritoneal sample was sent for culture at the emergency 
department.  Patient received vancomycin and gentamycin at ___.
.
She denies any skin changes around her PD catheter site or 
drainage from around the site. She also denies diffuse abdominal 
pain or changes to the appearance of dialysis fluid. 
.
At the ___ ED, initial vitals: 97.9 89 ___ 98%. EKG 
showed sinus rhythm with < 1mm STD in the lateral leads 
consistent with previous EKGs. Renal was also notified of the 
patient's admission who assessed the patient and did not feel 
that the patient was volume overloaded. 
.  
Currently, the patient is lying in bed with no specific 
complaints.   
.  
ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, chest pain, 
abdominal pain, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  

 
Past Medical History:
MEDICAL HISTORY:
--Hypertension
--Obesity
--Anemia
--Severe depression
--Anxiety
--Type 2 DM complicated by nephropathy leading to end-stage 
renal disease and initiation of peritoneal dialysis on ___. 
--Diverticulitis
--Lower GI bleed
--Gout
--Hyperlipidemia
--Insomnia
--Urinary tract infections   
.  
SURGICAL HISTORY:
--s/p hysterectomy  
--s/p gastric bypass 2 or ___ years ago  
--s/p lumpectomy  
--s/p vein stripping 
 
Social History:
___
Family History:
Her mother died at the age of ___- had h/o MI and died of sepsis. 
 Her father died at the age of ___ from stroke.  There is no 
significant family history of cancers.  Her daughter has been 
told that she has prediabetes. 

 
Physical Exam:
Admission physical exam:
VS - Temp 97.9 F, BP 134/48, HR 103, RR 20, O2-sat 100% RA  
GENERAL - well-appearing man in NAD, comfortable, appropriate  
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  
NECK - supple, no thyromegaly, no JVD
LUNGS - CTA bilat, no r/rh/wh, good air movement, resp 
unlabored, no accessory muscle use  
HEART - RRR, nl S1-S2, soft ___ systolic murmur best appreciated 
at the ___
ABDOMEN - NABS+, soft/NT/ND, no masses or HSM, no 
rebound/guarding, skin around the peritoneal catheter site 
non-erythematous with no drainage.   
EXTREMITIES - WWP, no c/c/e, 1+ DPs bilaterally.   
SKIN - no rashes or lesions   
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout, 
.
Discharge physical exam:
Vitals: T 98.2 BP 104/68 (70-125/42-57) HR 65 RR 16 O2 Sat 97% 
on RA
General: Chronically ill appearing patient lying in bed in NAD. 
HEENT: EOMI. MMM. OP without erythema, exudate, or ulcerations.
CV: RRR. No M/R/G appreciated. 
Lungs: CTAB. Nml work of breathing. No crackles or wheezes. No 
accessory muscle use.
Abdomen: NABS+. Soft. NT/ND. Peritoneal catheter in place in the 
LLQ. Bandage overlying the catheter entry site that is c/d/i.
Ext: WWP. No clubbing, cyanosis, or edema.

 
Pertinent Results:
Admission labs:
___ 04:00PM BLOOD WBC-13.7* RBC-3.28* Hgb-10.0* Hct-30.3* 
MCV-92 MCH-30.4 MCHC-32.9 RDW-14.1 Plt ___
___ 04:00PM BLOOD Neuts-84.6* Lymphs-11.6* Monos-2.9 
Eos-0.5 Baso-0.4
___ 04:00PM BLOOD Glucose-128* UreaN-58* Creat-10.1*# 
Na-139 K-3.2* Cl-95* HCO3-27 AnGap-20
___ 04:00PM BLOOD ALT-29 AST-24 CK(CPK)-53 AlkPhos-64 
TotBili-0.2
___ 04:00PM BLOOD Albumin-3.4* Calcium-8.8 Phos-4.8* Mg-2.4
.
Chest x-ray: 
FRONTAL AND LATERAL CHEST RADIOGRAPHS: The heart size is normal. 
The hilar and mediastinal contours are within normal limits. 
There is no pneumothorax, focal consolidation, or pleural 
effusion. IMPRESSION: No acute intrathoracic process.
.
TTE ___: The left atrium and right atrium are normal in 
cavity size. No atrial septal defect or patent foramen ovale is 
seen by 2D, color Doppler or saline contrast with maneuvers. 
Regional left ventricular wall motion is normal. Left 
ventricular systolic function is hyperdynamic (EF>75%). There is 
a moderate resting left ventricular outflow tract obstruction 
(difficult to precisely quantify, but likely in the vicinity of 
___ mmHg). Right ventricular chamber size and free wall motion 
are normal. The diameters of aorta at the sinus, ascending and 
arch levels are normal. The number of aortic valve leaflets 
cannot be determined. There is no aortic valve stenosis. No 
aortic regurgitation is seen. A late systolic jet of mild (1+) 
mitral regurgitation is seen. There is a trivial/physiologic 
pericardial effusion.
IMPRESSION: Hyperdynamic left ventricular systolic function with 
moderate resting LVOT obstruction. Mild functional late systolic 
mitral regurgitation. Borderline elevated pulmonary pressures.  
.
Chest CTA: 
FINDINGS: The visualized thyroid is unremarkable. There is no 
filling defect seen in the pulmonary arteries to the segmental 
level. Subsegmental pulmonary arteries are limited by 
respiratory motion. The great vessels are normal in caliber. 
There is no aortic abnormality. There is no mediastinum, hilar, 
or axillary lymphadenopathy. There is a small pericardial 
effusion. There are extensive coronary artery calcifications. 
The esophagus is normal. The airways are patent to the 
subsegmental level, there are tracheobronchial calcifications.
There is a 3-mm calcified nodule in the right middle lobe. There 
is a 3 mm
pulmonary nodule in the right upper lobe (2,14). No other 
nodules are seen. Mild dependent basilar atelectasis. There is 
no evidence of pleural effusion. No evidence of pneumonia.
Evaluation of the intra-abdominal viscera is limited. Patient is 
status post gastric surgery. There is free fluid seen in the 
upper abdomen. Correlate clinically.
IMPRESSION:
1. No evidence of pulmonary embolus.
2. There is free fluid seen in the upper abdomen. Correlate 
clinically.
3. 3 mm pulmonary nodule in the right upper lobe (2,14). If low 
risk, no
follow up needed. If high risk, 12 month follow up CT should be 
done. 
.
Microbiology:
___ Blood culture PENDING
.
Discharge labs: 
___ 07:10AM BLOOD WBC-8.6 RBC-2.97* Hgb-9.0* Hct-26.9* 
MCV-91 MCH-30.5 MCHC-33.6 RDW-14.0 Plt ___
___ 07:10AM BLOOD Glucose-76 UreaN-57* Creat-10.1* Na-138 
K-3.3 Cl-99 HCO3-26 AnGap-16
___ 07:10AM BLOOD Calcium-8.3* Phos-5.5* Mg-2.3
 
Brief Hospital Course:
OSH peritoneal cultures: negative for polys and organisms. NGTD

___ year old female with a past medical history of HTN, HLD, 
obesity s/p gastric bypass, anemia, and ESRD on peritoneal 
dialysis who presented to ___ emergency department with 
increasing weakness over the past ___s shortness 
of breath found to be profoundly orthostatic whose symptoms were 
thought to be secondary to over-dialysis.
.  
# Shortness of breath/dizziness: Upon presentation, the patient 
did not appear volume overloaded despite recent development of 
anuria. Given her long-standing history of diabetes there was 
concern that the patient's symptoms could be due to coronary 
artery disease; however, review of the patient's record shows 
that she had a recent stress test that did not show evidence of 
ischemia. An EKG did not show changes from prior, and CK-MB 
fraction was negative. Chest x-ray did not show evidence of 
volume overload or infection. She was found to be very 
orthostatic, and on ambulation, the patient desaturated to low 
___. During this episode of desaturation, the patient was 
profoundly short of breath with subjective chest palpitations 
and dizziness. With rest, the patient recovered. Patient 
underwent CTA for concern for PE as cause of symptoms which was 
negative. ECHO was notable for a hyperdynamic state concerning 
for a hypovolemic state. The patient's orthostasis and ECHO 
findings were attributed to the patient's restricted fluid 
consumption. Renal adjusted the patient's peritoneal dialysis, 
and she was also encouraged to increase her fluid consumption. 
Of note telemetry had no events. On day of discharge, with 
ambulation, the patient was less orthostatic (without symptoms) 
and did not desaturate on ambulation. The patient has follow-up 
arranged with her outpatient nephrologist regarding peritoneal 
dialysis. 
.
# End-stage renal disease on peritoneal dialysis: Secondary to 
diabetic nephropathy. Patient is pursing kidney transplant at 
___ and is followed by Dr. ___. The patient has been 
stable on peritoneal dialysis. Renal was consulted on admission 
and peritoneal dialysis was continued through the admission. 
Given the patient's extreme orthostasis, the patient's dialysis 
was adjusted per renal. Recommendations were made for the 
patient to increase consumption of fluids to prevent symptoms 
from developing. Outside hospital cultures of peritoneal fluid 
were followed during the admission as there was concern for 
peritonitis; gram stain was negative for PMNs and bacterial. 
Preliminary cultures were no growth to date. The patient did not 
receive antibiotics during her hospitalization at ___ her 
peritoneal dialysis catheter site was non-erythematous without 
purulence. 
.
# Incidental findings of pulmonary nodules on CT scan:  3mm 
nodule in right lung noted on CTPA.  However, Ms ___ is 
low-risk as she has no identifiable risk factors, so f/u imaging 
is not required.  However, if risk factors are identified, then 
12 month f/u CT scan is warranted.  
.
CHRONIC ISSUES:
# Type 2 diabetes complicated by peripheral neuropathy and 
nephropathy: Patient is on lantus and humalog as an outpatient. 
Last HgbA1c 6.8 in ___. The patinet's home lantus dose 
was continued through the admission as was a humalog sliding 
scale.  There were no events of hypoglycemia during the 
hospitalization. 
.
# Hypokalemia: Patient was supplemented with oral potassium 
chloride as needed through the admission. 
.
# Anemia: Hematocrit was trended through the admission and 
remained stable. Patient's anemia likely related to patient's 
end-stage renal disease. Patient received a dose of Epogen 
during the admission as she had missed her dose that she 
receives as an outpatient. 
.
# Hypertension: Continued home metoprolol through the admission. 

.
# Hyperlipidemia: Patient also had complaints of weakness. Given 
her use of statins, there was concern for statin-associated 
myopathy. CK was negative. Continued home Crestor through the 
admission. 
.
TRANSITION OF CARE:
#CODE STATUS: FULL CODE (confirmed)
#Pending studies:
--Blood culture

 
Medications on Admission:
Medications - Prescription
INSULIN GLARGINE [LANTUS] -  (Prescribed by Other Provider: Dr.
___ at ___ - 100 unit/mL Solution - 23 units at bedtime
LORAZEPAM - 2 mg Tablet - 1 Tablet(s) by mouth qhs for anxiety
___ ALSO take ___ tablet bid prn anxiety
METOPROLOL SUCCINATE -  (Prescribed by Other Provider) - 25 mg
Tablet Extended Release 24 hr - 1 Tablet(s) by mouth once a day
per pt 10 mg daily
ROSUVASTATIN [CRESTOR] - 40 mg Tablet - 1 Tablet(s) by mouth 
once
a day
.
Medications - OTC
CETIRIZINE [ZYRTEC] -  (OTC) - Dosage uncertain

 
Discharge Medications:
1. lorazepam 1 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 
 
2. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: 
One (1) Tablet Extended Release 24 hr PO once a day.  
3. sertraline 100 mg Tablet Sig: One (1) Tablet PO once a day.  
4. ketoconazole 2 % Cream Sig: One (1) Appl Topical BID (2 times 
a day).
Disp:*QS tube* Refills:*0*
5. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap 
PO DAILY (Daily).  
6. calcium acetate 667 mg Capsule Sig: One (1) Capsule PO TID 
W/MEALS (3 TIMES A DAY WITH MEALS).  
7. polyethylene glycol 3350 17 gram Powder in Packet Sig: One 
(1) Powder in Packet PO DAILY (Daily).  
8. melatonin 5 mg Tablet Sig: One (1) Tablet PO at bedtime as 
needed for insomnia.  
9. Zyrtec 10 mg Tablet Sig: One (1) Tablet PO at bedtime.  
10. insulin glargine 100 unit/mL Solution Sig: ___ (23) 
units  Subcutaneous at bedtime.  
11. insulin lispro 100 unit/mL Solution Sig: units according to 
home sliding scale units according to home sliding scale 
Subcutaneous Three times daily prior to meals.  
12. mupirocin 2 % Ointment Sig: One (1) application  Topical 
once a day.  
13. Crestor 40 mg Tablet Sig: One (1) Tablet PO once a day.  
14. Epogen  Injection

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary diagnosis:
Shortness of breath

Secondary diagnosis:
End-stage renal disease
Type 2 Diabetes Mellitus complicated by diabetic nephropathy 
Hypertension
Depression 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you during your hospitalization 
at ___. 

You were hospitalized with shortness of breath, palpitations, 
and dizziness. Imaging of your chest was reassuring and did not 
show evidence of clot or infection in the lung as an explanation 
for your symptoms. The cause of your symptoms was thought to be 
due to over ultrafiltration during peritoneal dialysis. You will 
have follow-up arranged with your outpatient nephrology (kidney) 
doctor next week; keep this appointment. 

We encourage you to drink fluid (no more than 2 liters per day) 
to ensure that these symptoms do not continue or worsen.  

Take all medications as instructed. Note that the following 
medication changes were made during this admission:
1. *NEW* Ketoconazole 2% cream 1 application twice daily to the 
area between your right ___ and ___ toes. 
Otherwise, no other medication changes have been made. 

Keep all hospital follow-up appointments. Your ___ 
hospital follow-up appointments are listed below.  
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-23 | hadm_id=21217423

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Penicillins / Latex
 
Attending: ___.
 
Chief Complaint:
ESRD
 
Major Surgical or Invasive Procedure:
Cadaveric Kidney Transplant ___

 
History of Present Illness:
___ y/o female with history of DM 1 for ___ years, triopathies, 
now on peritoneal dialysis for 18 months who presents for kidney 
transplant.
The patient reports no recent fever or chills. Denies chest pain 
or shortness of breath. History of gastric bypass about ___ years 
ago, and recent evaluation for persistent chronic nausea and 
retching (without vomiting) by Dr ___. She does have a 
pancreatic cyst that has been described as either chronic
pancreattis or IPMN, but has been stable for the past several 
years per his report. The patient has been on peritoneal 
dialysis for approximately 18
months. Since the placement of the catheter the patient has 
never had peritonitis or any mechanical problems with the 
catheter. She uses the cycler at home for 5 total exchanges, and 
has drained to dry prior to admission today.
The patient also has significant neuropathy that limits her 
mobility and has been a cause of recent falls at home. She uses 
a wheelchair or is assisted by her husband.
The patient was recently seen by Dr ___ evaluation of a 
buttock lesion, unsure if this was related to a recent fall. A 
CT was performed showing calcification of the subcutaneous soft 
tissues in the left buttock region. Of note, Heavily calcified 
aorta and branch vessels and there is nonspecific soft 
tissue stranding around one of the branches of the SMA which is 
new.
 
Past Medical History:
MEDICAL HISTORY: 
- ESRD on PD (initiated ___  
- Type 2 DM c/b peripheral neuropathy, autonomic dysfunction 
(orthostatic hypotension), ESRD  
- HTN  
- HL  
- Depression  
- Anxiety  
- Insomnia
- Chronic pancreatitis  
- s/p lithotripsy and stent placement for R ureteral stone ___ 
(Dr. ___
- h/o Diverticulitis
- h/o Lower GI bleed
- h/o Gout
- h/o Urinary tract infections   
  
SURGICAL HISTORY:
--s/p hysterectomy  
--s/p gastric bypass 2 or ___ years ago  
--s/p lumpectomy  
--s/p vein stripping 
 
Social History:
___
Family History:
Her mother died at the age of ___- had h/o MI and died of sepsis. 
 Her father died at the age of ___ from stroke.  There is no 
significant family history of cancers. Her daughter has 
pre-diabetes.  

 
Physical Exam:
VS: 98.2, 105, 143/67, 20, 98% RA, wt 61.7 kg
General: Frail, anxious
HEENT: No scleral icterus, no oral thrush or lesions
Card: RRR, no M/R/G
Lungs: CTA bilaterally
Abdomen: Soft, non-tender, PD catheter in place, exit site 
C/D/I,
old gastric bypass scar
Extr: mild lower extremity edema, 2+ femoral pulses bilaterally,
1 + DPs bilaterally, feet cool, pale
Buttock/skin: Left buttock near anus is grey/discolored.
approximately ___ cm solid "nodes" can be palpated. (CT reports
calcifications) No open areas on sacrum or at the site of the
buttock lesion. Several dark pink lesions noted on left shoulder
and legs, no drainage or bleeding, dry skin overall noted, no
rashes.
Neuro: A+O x 3

 
Pertinent Results:
___ 07:01PM   GLUCOSE-97 UREA N-48* CREAT-6.4*# SODIUM-140 
POTASSIUM-4.0 CHLORIDE-103 TOTAL CO2-21* ANION GAP-20
___ 07:01PM   CALCIUM-8.0* PHOSPHATE-6.1* MAGNESIUM-2.0
___ 07:01PM   WBC-14.2* RBC-3.91*# HGB-11.3*# HCT-35.2*# 
MCV-90 MCH-29.0 MCHC-32.2 RDW-15.5
___ 07:01PM   PLT COUNT-279
___ 05:13PM   ___ PH-7.39
___ 05:13PM   GLUCOSE-104 LACTATE-1.0 NA+-134 K+-3.6 CL--99 
TCO2-26
___ 05:13PM   HGB-6.6* calcHCT-20
___ 05:13PM   freeCa-0.92*
___ 04:51PM   ___ PH-7.39 INTUBATED-INTUBATED 
VENT-CONTROLLED COMMENTS-SPEC. ___ 04:51PM   GLUCOSE-48* LACTATE-0.5 NA+-140 K+-1.5* 
CL--128* TCO2-10*
___ 04:51PM   HGB-3.4* calcHCT-10
___ 04:51PM   freeCa-0.61*
___ 10:55AM   GLUCOSE-44* UREA N-58* CREAT-7.8*# SODIUM-140 
POTASSIUM-4.1 CHLORIDE-98 TOTAL CO2-29 ANION GAP-17
___ 10:55AM   estGFR-Using this
___ 10:55AM   ALT(SGPT)-25 AST(SGOT)-18
___ 10:55AM   ALBUMIN-2.4* CALCIUM-8.1* PHOSPHATE-5.5* 
MAGNESIUM-2.3
___ 10:55AM   HCG-12
___ 10:55AM   WBC-9.8 RBC-2.93* HGB-8.1* HCT-26.0* MCV-89 
MCH-27.8 MCHC-31.3 RDW-15.5
___ 10:55AM   PLT COUNT-311
___ 10:55AM   ___ PTT-30.3 ___ F admitted from home for a deceased donor kidney transplant.

On ___, she underwent perfect match renal transplant. 
Surgeon was Dr. ___. Please refer to operative note 
for details. She received routine induction immunosuppression to 
include mycophenolate, 500 mg of Solu-Medrol and Simulect. At 
the end of the procedure the transplanted kidney was noted to be 
nicely pink with good pulse and thrills in the arteries. A 
double J ureteral stent and ___ drain were placed. ___ drain 
was positioned around the anastomosis and adjacent to the 
bladder anastomosis.

She was taken to the PACU post-operatively and was 
hemodynamically stable. Pain was not well controlled in the 
PACU, so she was changed from a morphine PCA to a dialuadid PCA. 
She also had several episodes of apnea without 02 desaturations, 
likely secondary to oversedation. She was transferred to the 
floor on continous O2 monitoring with a CPAP ordered for sleep. 
She was started on a clear liquid diet, which she tolerated, and 
a bowel regimen. On POD 1 she was found to be increasingly 
somnolent, her PCA lockout time was increased to 15 minutes, 
after which the patient was more alert and responsive. On POD 1 
her UOP decreased to ___. She was given a 500cc IVF bolus 
with minimal response, her foley was flushed and she immediatly 
put out 615cc of urine; her UOP increased steadily to 
100-200cc/hr by POD 2. 
Continuous O2 monitoring was discontinued on POD 2 after 
reevaluation by respiratory therapy. She was started on a 
regular diet on POD 2, given her history of IDDM, a consult was 
placed with the ___, who continued to follow 
and manage her diabetes during her hospital stay. She also began 
to experience episodes of hypertension, with systolic blood 
pressures elevated to the 180s-190s (supine). Blood pressures 
taken while the patient was seated were found to be in the 150s 
systolic. Transplant nephrology was consulted who recommeneded 
starting her on 12.5mg of PO metoprolol BID. On POD 3 she showed 
no response to PO metoprolol, with systolic blood pressures as 
high as 210s. She was given 15mg of IV metoprolol, which also 
yielded no response. After a 5mg dose of IV hydarlazine her 
systolic blood pressure decreased to the 150s systolic. On POD 4 
she was started on 5mg amlodipine and her metoprolol was 
increased to 50mg BID. IVF was discontinued. Amlodipine was 
further increased on ___ for sbp in 170-190 range. 

She was placed on the immunosuppresion protocol post-operatively 
which consisted of steroid taper, Cellcept, Prograf which was 
started on POD 1 and Simulect (intraop  and postop day 4). On 
POD 5 she completed her steroid taper, her blood pressures 
moderated, with systolic BP in the 140-160 range. At that time 
the patient was tolerating a regular diet, ambulatory and her 
pain was well controlled. On the day of discharge she and her 
husband were provided with medication teaching and were 
comfortable with administering her medication regimen at home. 

Physical therapy evaluated and recommended home with services. A 
previously scheduled Gastroenterology appointment for ___ 
was canceled and will need to be rescheduled.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Calcium Acetate ___ mg PO TID W/MEALS 
2. Epoetin Alfa 1000 units SC WEEKLY Start: HS 
3. Glargine 16 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
4. Lorazepam 2 mg PO HS 
5. Midodrine 5 mg PO BID 
8 AM and 2 ___ 
6. Mupirocin Cream 2% 1 Appl TP DAILY PD exit site 
7. Ondansetron 4 mg PO BID 
8. Klor-Con M20 *NF* (potassium chloride) 20 mEq Oral daily 
9. Rosuvastatin Calcium 40 mg PO HS 
10. Sertraline 100 mg PO DAILY 
11. Cetirizine *NF* 10 mg Oral HS 
12. melatonin *NF* 3 mg Oral HS 
13. Polyethylene Glycol 17 g PO DAILY 
14. Sodium Chloride 1 gm PO BID 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
ESRD now s/p cadaveric kidney transplant

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Please call the transplant clinic at ___ for fever, 
chills, nausea, vomiting, diarrhea, constipation, increased 
abdominal pain, pain over the graft kidney, decreased urine 
output, painful urination, blood in the urine, inability to 
tolerate food, fluids or medications, or other concerning 
symptoms.
Monitor the incision for redness, drainage or bleeding. 

Please have labs drawn every ___ and ___ at the ___ 
___ Deaconess lab in the ___ Building, ___ 
floor. Continue this schedule until further notice from the 
transplant clinic.
 
No lifting greater than 10 pounds
There have been many changes to your medication regimen. Please 
follow the medication sheet in your transplant binder
Urine output monitoring daily, bring copy to transplant clinic
BP monitoring daily. Call if > 160 systolic or less than 110 
systolic. Bring copy of report to clinic
Change JP drain sponge daily, monitor drain site for redness, 
drainage or bleeding. Drain and record the JP drain output and 
call if it increases significantly, stops completely or turns 
bloody, cloudy in appearance or develops a foul odor.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-22 | hadm_id=22547015

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___.
 
Chief Complaint:
Abdominal pain, nausea/vomiting

 
Major Surgical or Invasive Procedure:
___:  Cystoscopy, left retrograde pyelogram, left ureteral 
stent placement. Surgeon: ___, MD 

 
History of Present Illness:
This is a ___ F with ESRD on PD, DMII, HTN, HL, orthostatic 
hypotension, who presents with several days of abdominal pain, 
nausea, and vomiting. She reports that her abdomen began to feel 
tender about one week ago, but that 4 days ago the pain 
significant increased, especially with PD administration. 
Yesterday, she had severe pain with PD radiating to her back, 
and she felt that her abdomen was abnormally distended and 
'lumpy'. She has daily vomiting at baseline presumably due to 
autonomic dysfunction, but had increased nausea with vomiting 
and heaving up to 10x three days ago and ___ two days ago. 
She has also been constipated, her last BM was 5 days ago 
despite taking her daily dose of Miralax; her last BM was solid 
and almost white. She has also noted night sweats, shaking 
chills, subjective fever, anorexia, and fatigue. She denies 
chest pain, shortness of breath, headache. 

Of note, the patient is currently on 40mg Prednisone QD for 
suspected temporal arteritis; she presented in late ___ with 
temporal headache and ESR 112; subsequent temporal biopsy was 
negative. She has also recently been suffering from orthostatic 
hypotension ___ autonomic dysfunction, however she has been off 
midodrine as her BP has been recently stable while on 
prednisone. 

In the ED, her initial VS were T 97.2 HR 108 BP 129/74 RR 16 O2 
95% RA. Labs were notable for WBC 38.1, normal LFTs/lipase. KUB 
negative for obstruction. CT abd/pelvis showed an obstructing 
3mm L mid ureteric stone with mild hydronephrosis and tiny 
non-obstructing right renal stones. It showed CBD dilation to 
11mm, without masses/stones. No appendicitis or diverticulitis 
noted. Blood cultures were drawn and patient was given 2g IV 
ceftriaxone. The patient was evaluated by nephrology/dialysis 
team and started on IP Vancomycin and IP cefepime. No peritoneal 
fluid was drawn prior to antibiotics. However, the patient had a 
bag of peritoneal dialysate from from earlier on ___ which was 
sent for culture/gram stain. Finally, the patient reports some 
BRB on toilet paper after straining for attempted BM while in 
ED, however cannot find RN documentation of this. 

On the floor, the patient's nausea and abdominal pain were 
significantly improved and she was relatively comfortable. She 
denied chills, fever.  
 
Past Medical History:
MEDICAL HISTORY: 
- ESRD on PD (initiated ___  
- Type 2 DM c/b peripheral neuropathy, autonomic dysfunction 
(orthostatic hypotension), ESRD  
- HTN  
- HL  
- Depression  
- Anxiety  
- Insomnia
- Chronic pancreatitis  
- s/p lithotripsy and stent placement for R ureteral stone ___ 
(Dr. ___
- h/o Diverticulitis
- h/o Lower GI bleed
- h/o Gout
- h/o Urinary tract infections   
  
SURGICAL HISTORY:
--s/p hysterectomy  
--s/p gastric bypass 2 or ___ years ago  
--s/p lumpectomy  
--s/p vein stripping 
 
Social History:
___
Family History:
Her mother died at the age of ___- had h/o MI and died of sepsis. 
 Her father died at the age of ___ from stroke.  There is no 
significant family history of cancers. Her daughter has 
pre-diabetes.  

 
Physical Exam:
Physical exam on admission: 
VITALS: T 98.2 BP 125/63  HR 78  RR 18  SpO2 97%RA
GENERAL: Well-nourished female, NAD, sitting in bed comfortably  

HEENT: PERRL, dry MM  
NECK: no LAD 
LUNGS: CTAB, no wheezes/crackles/rhonchi  
HEART: RRR, nl S1 S2, no murmur/rubs/gallops appreciated
ABDOMEN: +BS, soft. Diffuse tenderness to palpation, most 
pronounced in LLQ, without rebound or guarding. PD catheter in 
place without surrounding erythema, edema or drainage.   
BACK: No paraspinal tenderness. Bilateral CVA tenderness  
EXTREMITIES: No c/c/e  
NEUROLOGIC: A+OX3  

Physical exam on discharge: 
Examined by the cross cover team
 
Pertinent Results:
Labs on admission: 
___ 04:45PM BLOOD WBC-38.1*# RBC-4.21 Hgb-12.5 Hct-38.5 
MCV-92 MCH-    29.7 MCHC-32.4 RDW-15.3 Plt ___
___ 04:45PM BLOOD Neuts-96.0* Lymphs-1.8* Monos-2.1 Eos-0 
Baso-0
___ 04:45PM BLOOD Glucose-169* UreaN-72* Creat-9.0* Na-137 
K-4.4 Cl-    93* HCO3-26 AnGap-22*
___ 04:45PM BLOOD ALT-24 AST-25 AlkPhos-72 TotBili-0.2
___ 04:45PM BLOOD Lipase-20
___ 04:45PM BLOOD Albumin-3.1*
___ 05:50AM BLOOD Calcium-7.6* Phos-11.7*# Mg-2.2
___ 05:23PM BLOOD Lactate-1.9

Pertinent results: 
___ 05:50AM BLOOD ESR-72*
___ 05:50AM BLOOD CRP-168.9*
___ 06:55AM BLOOD Vanco-9.5*
___ 05:35AM BLOOD Vanco-12.9
___ 05:50AM BLOOD PTH-223*

Labs on discharge: 
___ 05:25AM BLOOD WBC-11.6* RBC-3.38* Hgb-9.9* Hct-31.1* 
MCV-92 MCH-29.2 MCHC-31.8 RDW-15.0 Plt ___
___ 05:25AM BLOOD Glucose-92 UreaN-52* Creat-7.8* Na-139 
K-3.1* Cl-96 HCO3-29 AnGap-17
___ 05:25AM BLOOD Calcium-7.4* Phos-6.6* Mg-2.2

Microbiology: 
___ 4:45 pm BLOOD CULTURE: Routine (Final ___: NO 
GROWTH. 
___ 5:00 pm BLOOD CULTURE: Blood Culture, Routine (Final 
___: 
      KLEBSIELLA OXYTOCA.    FINAL SENSITIVITIES. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___. Cefazolin interpretative criteria are based on a 
dosage 
          regimen of 2g every 8h. SENSITIVITIES: MIC expressed 
in MCG/ML
   _________________________________________________________
                             KLEBSIELLA OXYTOCA
                             |   
AMPICILLIN/SULBACTAM--   <=2 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----       S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

   Aerobic Bottle Gram Stain (Final ___: 
      GRAM NEGATIVE ROD(S).

___ 12:55 am DIALYSIS FLUID
      ACID FAST CULTURE AND SMEAR ADDED @ 0554 ON ___. 
   GRAM STAIN (Final ___: 
      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 
      This is a concentrated smear made by cytospin method, 
please refer 
      to hematology for a quantitative white blood cell count.. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. 

   ACID FAST CULTURE (Pending): 

___ 7:45 pm BLOOD CULTURE      1 OF 2.  Routine (Pending): 
___ 9:25 pm BLOOD CULTURE      RECEIVED  ON ___ # 2. 
         Blood Culture, Routine (Pending): 

EKG ___
Sinus rhythm. Within normal limits. Compared to the previous 
tracing  
of ___ no significant change.  
     Intervals Axes 
Rate PR QRS QT/QTc P QRS T 
92 114 70 366/422 49 35 73 
 
Imaging:
___
- KUB: The stomach contains an air-fluid level but does not 
appear distended.  Stool and air are seen throughout most 
portions of the colon, including the rectum.  A few air-fluid 
levels in the pelvis are probably colonic.  Although a paucity 
of small bowel gas limits assessment somewhat, no dilated loops 
of large or small bowel are seen.  There is no free air.  
Surgical clips are present along the left upper quadrant.  There 
is a catheter coiled in the pelvis, possibly for peritoneal 
dialysis.  Prominent calcified vessels are noted about the 
pancreatic head as well as the splenic artery.  Their presence 
may be associated with collateral pathways between celiac and 
superior mesenteric arterial distributions.  Mild spinal 
degenerative changes are noted with small osteophytes along the 
mid and lower portions of the lumbar spine, as well as suspected 
facet joint degenerative changes at the lumbosacral junction. 
IMPRESSION:  Few distal colonic air-fluid levels, which are 
non-specific, without findings strongly suggestive of 
obstruction.  No evidence of free air. 
- CT abd/pelvis w/o contrast:
CT CHEST:  Linear scarring is seen in the lung bases.  Trace 
peribronchovascular ground-glass opacity is seen in the right 
lower lung (2, 1), nonspecific and similar as on prior exams.  
There is also dependent atelectasis in the right base.  There is 
no pleural effusion.  The heart is normal in size.  There is 
relatively focal anterior pericardial fluid, appearance similar 
as compared to ___.  Dense multivessel coronary 
arterial calcifications are present. 
CT ABDOMEN:  Small perihepatic ascites is re-demonstrated, in 
keeping with history of peritoneal dialysis.  The gallbladder 
appears moderately distended but without definite stranding 
around it or pericholecystic fluid.  Note is made of dilated CBD 
to at least 11 mm without obvious obstructing stone or mass, 
although assessment is highly limited due to non-contrast 
technique.  This is increased as compared to prior MRI dated 
___.  A subcentimeter lesion seen in the liver on prior 
MRI is not well visualized.  The pancreas is diffusely atrophic, 
in keeping with chronic pancreatitis.  Abnormal configuration of 
pancreatic duct with cystic changes appears similar but is 
better demonstrated on prior MRCP dated ___. The left 
adrenal gland demonstrates stable thickening without nodularity. 
 The right adrenal gland appears normal.  There is a 3 mm stone 
in the mid left ureter and the left ureter is mildly dilated, 
although there is little caliber change at the site of the stone 
in the mid ureter.  Note is made of a single focus of air in the 
left renal pelvis (2, 27), which could represent air from gas 
forming organism in pyelitis, or alternatively air refluxed from 
the bladder could be considered.  There is no obstructing 
nephropathy on the right.  Multiple tiny non-obstructing stones 
are seen in the right kidney.  There is no right-sided 
hydronephrosis or hydroureter.  Small and large bowel loops are 
normal in caliber.  The appendix appears normal.  No free air or 
free fluid.  Extensive atherosclerotic disease is seen in the 
infrarenal aorta extending into the common iliac arteries 
without aneurysm. 
CT PELVIS:  At least two stones are seen in the bladder.The 
distal ureters, rectum, and prostate appear within normal 
limits.  No pelvic lymphadenopathy.  A peritoneal dialysis 
catheter is coiled in the pelvis between bowel loops.  Trace 
fluid is seen in the right hemipelvis. 
BONE WINDOW:  There is multilevel moderate thoracolumbar 
spondylosis.  There have been prior bilateral anterolateral rib 
fractures. 
IMPRESSION: 
1.  3 mm stone in the mid left ureter with upstream mild 
hydronephroureter although the degree of obstruction is 
uncertain since the ureter does not change caliber at the site 
of the stone.  Single focus of air in the left renal pelvis 
raises concern for pyelitis due gas- forming organism although 
refluxed air from the bladder could be considered since the 
bladder contains air, but this possibility would also require 
vesicoureteral reflux.  Close monitoring is advised. 
2.  Non-obstructing tiny right renal stones. 
3.  Bladder stones. 
4.  Small amount of ascites, which is anticipated in the setting 
of peritoneal dialsysis. 
5.  Diffuse atherosclerotic disease. 
6.  CBD dilatation to 12 mm without obvious obstructing mass or 
stone, 
increased since preceding MRCP dated ___.  Correlate with 
laboratory data and consider MRCP for further assessment if 
clinically indicated. 
- CXR PA/Lateral: The heart is normal in size.  The mediastinal 
and hilar contours appear unchanged.  The lungs appear clear.  
There are no pleural effusions or pneumothorax.  Mild 
degenerative changes are similar along the thoracic spine. 
IMPRESSION:  No evidence of acute disease.

___
- RUQ blood culture: Mild perihepatic ascites evident in keeping 
with history of peritoneal dialysis.  The liver is homogeneous 
in echotexture without discrete masses or lesions.  There is no 
intrahepatic biliary ductal dilatation.  The common bile duct is 
dilated to 1.2 cm in maximal dimension, but tapers smoothly to a 
level of 0.8 cm in the distal aspect.  However, the most distal 
aspect at the level of the pancreas, as well as the pancreas in 
its entirety are obscured due to overlying bowel gas.  The 
gallbladder is distended, but without gallstones.  There is no 
gallbladder wall edema or hyperemia evident.  The visualized 
aspects of the right kidney are unremarkable.  Doppler 
assessment of main portal vein shows patency and hepatopetal 
flow.   
IMPRESSION:  
1. Minimal perihepatic ascites in keeping with peritoneal 
dialysis. 
2. Dilated common bile duct without intrahepatic biliary ductal 
dilatation.  Unable to evaluate common bile duct at level of 
pancreatic head. No stones in visualized aspect of CBD. No 
cholelithiasis 

___
- renal U/S: The right kidney measures 8.8 cm and is echogenic 
consistent with provided history of end-stage renal disease.  
The left kidney measures 10.0 cm. Trace perinephric fluid noted 
on the left. No evidence of hydronephrosis bilaterally.  
Multiple non-obstructing stones are identified within the left 
kidney, the largest of which is in the lower pole measuring 3 
mm.  The bladder is collapsed and not well evaluated. 
IMPRESSION: 
Smaller echogenic kidney on the right consistent with provided 
history of 
renal disease.  No hydronephrosis evident bilaterally.  Multiple 
non-obstructing stones on the left. 

Pathology:
___
- peritoneal fluid: negative for malignant cells
 
Brief Hospital Course:
This is a ___ F with ESRD on PD presenting with abdominal pain, 
nausea and vomiting, leukocytosis, and constipation, with 
obstructing L ureteral stone on CT, CVA tenderness, and 
gram-negative bacteremia, most likely consistent with 
pyelonephritis c/b ileus. 

Active issues: 
#PYELONEPHRITIS/NEPHROLITHIASIS:  The patient presented with 
fevers, chills, nausea/vomiting, malaise, leukocytosis with WBC 
to 38, along with CVA tenderness on exam and obstructing L 
ureteral stone on CT, all concerning for pyelonephritis. The 
patient was afebrile on admission but with CVA tenderness and as 
well as moderate point tenderness in the LUQ. The patient was 
originally started on IP cefepime and IP vancomycin for concern 
of PD related peritonitis, however, with ongoing CVA tenderness 
and after discussions with nephrology and urology, the cefepime 
was transitioned to IV, and on ___ the patient underwent 
cystoscopy with left retrograde pyelogram and left ureteral 
stent placement performed by Dr. ___, without 
complication. Following the procedure and with initiation of IV 
cefepime, the patient's CVA tenderness and LUQ point tenderness 
resolved. The patient remained afebrile and her WBC trended down 
over the course of her admission.  She was transitioned to 
ciprofloxacin and tolerated it well prior to discharge.  The 
plan was to leave the stent in for 1 week on Flomax prior to 
removal of stent.  Patient will need to discuss with urology 
about need of Flomax afterward given her high risk of stone 
formation given h/o gastric bypass.

# Klebsiella SEPTICEMIA: One of two blood cultures from ___ 
grew out gram-negative rods, which speciated as Klebsiella 
oxytoca, sensitive to cefepime and ciprofloxacin, thought likely 
secondary to pyelonephritis. The patient was afebrile on 
admission with stable vital signs. She had already been started 
on IV cefepime prior to the report of growth on blood culture 
and was continued on IV cefepime until 24 hours before 
discharge, at which time she was transitioned to PO 
ciprofloxacin, which she tolerated well, and will continue at 
home until ___. She was afebrile with stable vital signs at 
discharge. 

#R/O PERITONITIS: The patient presented with nausea, vomiting, 
and abdominal pain with peritoneal dialysis, as well as an 
elevated periotoneal dialysate WBC, all concerning for 
peritonitis. Peritoneal fluid culture and gram stain showed no 
organisms and AFB smear (done out of concern for TB peritonitis 
due to elevated monocytes in peritoneal fluid) was negative. The 
patient was started on IP vancomycin and IP cefepime for 
peritonitis. Her abdominal pain rapidly improved and she was 
able to continue peritoneal dialysis without any ongoing 
discomfort. In discussion with nephrology, concern for true 
infectious peritonitis was thought to be low and the patient's 
IP cefepime was transition to IV cefepime on ___, and her IP 
vancomycin was discontinued on ___. The patient remained 
afebrile and continued on peritoneal dialysis without any pain 
or discomfort, and her peritoneal dialysate fluid culture 
remained negative. She was discharged home with instructions to 
continue with good sterile technique for home PD. 

#CONSTIPATION: On presentation the patient had not had a bowel 
movement for ___ days; she takes daily miralax at home and is 
normally regular. She had passed a small amount of gas and a KUB 
on admission showed few distal colonic air-fluid levels without 
findings strongly suggestive of obstruction; though consistent 
with ileus. As constipation can interfere with the efficacy of 
peritoneal dialysis, the patient was started on an aggressive 
bowel regimen of 2L Golytely with good response. She was 
transitioned to standing Miralax and Senna without further 
constipation.   

# R/O TEMPORAL ARTERITIS: The patient had been diagnosed with 
possible temporal arteritis in late ___ after presenting 
with bitemporal headache but without jaw pain or claudication. 
She had been started on 40mg prednisone daily. In discussion 
with the outpatient rheumatologist, suspicion for true GCA was 
thought to be low after negative temporal artery biopsy and the 
risks of immunocompromise due to steroid therapy concerning in 
light of her current presentation, and the patient was started 
on a fast prednisone taper which she will finish on ___ (had 10 
mg daily reduction from 40 mg while in house, then 5 mg x 7 days 
prior to discontinuation) 

#TYPE 2 DM: The patient reported that her blood sugars had 
recently been difficult to control, most likely due to recently 
initiated prednisone therapy. She was started on her home 
insulin regimen, however, she had persistent asymptomatic  
hypoglycemia in the mornings with AM glucose levels in the 
mid-40s to low ___. She was evaluated by endocrinology from 
___ and ___ basal insulin levels were altered, while allowing 
the patient to determine her own sliding scale doses. Her blood 
sugars were mainly stable, ranging 80-150, however peaking to 
over 300 before bedtime. She was discharged on an altered 
regimen of 18U Glargine at bedtime with the plan to follow up 
with ___ closely (per patient's request to transition back to 
___
 
Chronic issues:
#AUTONOMIC DYSFUNCTION/ORTHOSTASIS: The patient has baseline 
autonomic dysfunction as a complication of her diabetes, 
however, this had not been an issue immediately prior to her 
admission because her BPs were stable while on prednisone. Her 
blood pressures were stable during admission, ranging 110s-150s, 
despite prednisone taper and she denied light-headedness or 
dizziness on standing or ambulating. 

#ESRD on PD: The patient initiated peritoneal dialysis 14 months 
ago and is oliguric/anuric, with max ___ urine/day. She was 
continued on peritoneal dialysis per the recommendations of the 
nephrology/dialysis team without complication. Her electrolytes 
were monitored and repleted as necessary. She was continued on 
her home supplements, with the exception of her EPO, which she 
normally receives every ___ and would receive after 
discharge. All medications were renally dosed.  

#DEPRESSION/ANXIETY: The patient was continued on her home 
anti-depressant and home anxiety medication. Her mood remained 
stable throughout admission. 

#CHRONIC PANCREATITIS/CBD DILATION: On non-contrast abdominal CT 
on admission, note was made of moderate gallbladder distention 
with CBD dilation to at least 11mm but without obvious 
obstructing stone or mass (though with evaluation limited by 
non-contrast technique). The patient did not complain of RUQ 
pain. A follow-up RUQ ultrasound again revealed a dilated CBD 
without intrahepatic biliary duct dilatation but with limited 
ability to evalute the CBD at the pancreatic head. The patient 
had normal LFTs and was asymptomatic, so no further workup was 
pursued during admission. However, outpatient MRCP for CBD 
dilatation should be considered.

Transitional issues: 
#FOLLOW-UP: 
-Primary care: the patient will follow up with Dr. ___ on 
___ at 11:10am.  Consider MRCP/ERCP for evaluation of CBD 
dilatation.
-Urology: the patient will follow up with Dr. ___ on ___ at 
10:00am
-Endocrinology: the patient will follow up with Dr. ___ 
at ___ on ___ at 10:00am 
-Rheumatology: the patient will follow up with Dr. ___ on 
___ at 10:00am

#RESULTS PENDING: 
-___ Blood culture x2: pending
-___ Peritoneal dialysate Acid Fast Bacteria culture: pending
 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from Patient.
1. Glargine 26 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
2. PredniSONE 40 mg PO DAILY 
3. Rosuvastatin Calcium 40 mg PO DAILY 
4. Lorazepam 2 mg PO HS:PRN anxiety 
5. Ondansetron 4 mg PO Q8H:PRN nausea 
6. Sertraline 100 mg PO DAILY 
7. ZYRtec *NF* 10 mg Oral daily 
8. Polyethylene Glycol 17 g PO DAILY 
9. Calcium Acetate ___ mg PO TID W/MEALS 
10. Nephrocaps 1 CAP PO DAILY 

 
Discharge Medications:
1. Calcium Acetate ___ mg PO TID W/MEALS 
2. Lorazepam 2 mg PO HS:PRN anxiety 
3. Nephrocaps 1 CAP PO DAILY 
4. Ondansetron 4 mg PO Q8H:PRN nausea 
5. Polyethylene Glycol 17 g PO DAILY 
6. PredniSONE 5 mg PO DAILY Duration: 7 Doses 
start on ___ 
RX *prednisone 5 mg 1 tablet(s) by mouth daily Disp #*7 Tablet 
Refills:*0
7. Rosuvastatin Calcium 40 mg PO DAILY 
8. Sertraline 100 mg PO DAILY 
9. Tamsulosin 0.4 mg PO HS 
RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30 
Tablet Refills:*0
10. ZYRtec *NF* 10 mg Oral daily 
11. Ciprofloxacin HCl 250 mg PO Q24H 
Continue to take this medication until your final dose on 
___.  
RX *ciprofloxacin 250 mg 1 tablet(s) by mouth every 24 hours 
Disp #*12 Tablet Refills:*0
12. Glargine 18 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary diagnoses: 
- pyelonephritis
- klebsiella bacteremia/sepsis

Secondary diagnoses: 
-Type II Diabetes Mellitus
-End Stage Renal Disease on Peritoneal Dialysis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You were admitted to ___ on 
___ for abdominal pain, fever, nausea, and vomiting. 

It was initially thought that you may have either an infection 
in your abdomen or an infection in your left kidney. You were 
started on antibiotics in your peritoneal dialysis fluid as well 
as intravenous antibiotics. You did not have a fever in the 
hospital and your abdominal pain rapidly improved. We found 
stones in your left kidney based on the imaging studies, and 
thought that your symptoms had been due to a kidney infection, 
so you underwent a procedure to put a stent into the left ureter 
(tube between the kidney and the bladder). Additionally, you 
were found to have bacteria growing from your blood culture and 
were continued on intravenous antibiotics to treat this. You 
were switched to oral antibiotic medicine, Ciprofloxacin, which 
you will finish taking after discharge from the hospital. 

You should continue using good sterile technique with peritoneal 
dialysis at home as you have been.  It is important to make sure 
that you have bowel movement every day, because constipation can 
interfere with your peritoneal dialysis.

We contacted your rheumatologist for the prednisone taper, 
because your pathology report showed that you do not have an 
inflammation of the artery at your temple.  Therefore, you are 
going to be gradually tapered off from the prednisone.  This has 
affected your blood sugar, and the diabetes doctors from ___ 
helped to manage your blood sugar.  You can return to see them 
after this hospitalization.

Please note the change in your medication: 
-ADDITION of ciprofloxacin 250mg every 24 hours, which you will 
take until the evening of ___
-ADDITION of Flomax (tamsulosin) 0.4 mg every night until you 
see your urologist.
-DECREASE Lantus (Glargine) to 18 units QHS
-CHANGE your sliding scale (see medication sheet for details)
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-25 | hadm_id=23041305

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___.
 
Chief Complaint:
Left toe gangrene
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old female with PMH of IDDM c/b peripheral nephropathy
and retinopathy s/p renal transplant in ___,  HTN, who 
initially
presented to ___ for infection on her left 
third
toe x 1 week. About one week ago, the patient was trying to cut
her toe naul and accidentally cut the top of her left third toe.
She had been trying to keep the wound clear but then noticed 
that
on the day of presentation on ___ that the wound was red,
painful, and she had a black spot on the tip of her toe. She
never had a fever or chills.  She had a left toe x-ray at the 
OSH
that showed no evidence of fraction, dislocation, or
osteomyelitis.  At ___, she was treated for a
diabetic foot infection with vanco, cipro, Flagyl and was seen 
by
vascular who reported that her non-invasive testing was
consistent with multi level PAD. The vascular service at ___ recommended that she be transferred to ___ due to the
complexity of her illness and history of renal transplant as she
will have poor wound healing from her PAD. 

ABI/PVR were obtained that showed right toe pressure of 50 and
left of 18.

On arrival to the floor, patient reports feeling well with
continued tenderness. She has not had any fevers, chills, chest
pain, shortness of breath.
 

 
Past Medical History:
 Diabetes, insulin dependent, ? type I vs II  
 ESRD s/p Renal transplant in ___, baseline Cr  
 Hypertension  
 Hyperlipidemia  
 S/p gastric bypass  
 H/o GI bleed (lower, ___  
 Chronic cough, bronchiectasis s/p IVIG  
 Diabetic retinopathy  
 Anxiety/depression  
 Bipolar disorder  
 B12 deficiency  
 Gout  
 S/p TAH ___  
 Orthostatic hypotension  
 
Social History:
___
Family History:
No family history of diabetes or kidney disease  
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
VS:  98.1 ___
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
MMM  
NECK: supple, no LAD, no JVD  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles  
ABDOMEN: nondistended, nontender in all quadrants, no
rebound/guarding, no hepatosplenomegaly  
EXTREMITIES: no cyanosis, clubbing, or edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no
rashes  

DISCHARGE PHYSICAL EXAM
VITALS: Temp: 98.4 (Tm 98.8), BP: 150/42 manual (100-174/42
manual-77), HR: 51 (51-62), RR: 18, O2 sat: 97% (94-97), O2
delivery: Ra     
GENERAL: well developed, well nourished in NAD 
HEENT: sclera anicteric, MMM
CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops
LUNGS: CTABL, no wheezes, rales, or rhonchi, normal WOB 
ABDOMEN: soft, non-tender, non-distended
EXTREMITIES: warm, cap refill <2 sec in bilateral ___ toes,
unable to palpate DPs or R TP, L TP 1+, L ___ toe w 1cmx1cm
dry, necrotic ulcer w surround erythema  
NEURO: AOx3, face symmetric, moving all extremities with purpose

 
Pertinent Results:
ADMISSION LABS

___ 05:10AM BLOOD WBC-5.5 RBC-4.27 Hgb-12.4 Hct-39.2 MCV-92 
MCH-29.0 MCHC-31.6* RDW-14.7 RDWSD-49.4* Plt ___
___ 05:10AM BLOOD ___ PTT-28.7 ___
___ 05:10AM BLOOD Glucose-113* UreaN-11 Creat-1.0 Na-143 
K-4.9 Cl-106 HCO3-28 AnGap-9*
___ 05:10AM BLOOD ALT-17 AST-17 AlkPhos-84 TotBili-0.6
___ 05:10AM BLOOD Calcium-9.0 Phos-3.9 Mg-1.8

PERTINENT INTERVAL LABS
___ 05:04AM BLOOD CK-MB-1 cTropnT-<0.01
___ 05:04AM BLOOD CRP-2.5
___ 05:04AM BLOOD IgG-933 IgA-188 IgM-79
___ 05:10AM BLOOD Vanco-13.8
___ 05:04AM BLOOD Vanco-19.4
___ 09:24PM BLOOD Vanco-19.6
___ 05:10AM BLOOD tacroFK-6.0
___ 05:04AM BLOOD tacroFK-6.1
___ 05:11AM BLOOD tacroFK-5.6
___ 04:56AM BLOOD tacroFK-4.6*
SED RATE BY MODIFIED 9  (<=30)

DISCHARGE LABS
___ 04:56AM BLOOD WBC-5.5 RBC-4.28 Hgb-12.4 Hct-40.0 MCV-94 
MCH-29.0 MCHC-31.0* RDW-14.6 RDWSD-49.7* Plt ___
___ 04:56AM BLOOD ___ PTT-28.1 ___
___ 04:56AM BLOOD Glucose-137* UreaN-14 Creat-0.9 Na-145 
K-4.6 Cl-109* HCO3-26 AnGap-10
___ 04:56AM BLOOD Calcium-8.9 Phos-4.0 Mg-1.6

MICROBIOLOGY
None

IMAGING AND STUDIES
___ VENOUS DUP UPPER EXT BIL
Patent cephalic and basilic veins bilaterally with diameters as 
listed above. 

___ VENOUS DUP LOWER EXT BIL
The great and small saphenous veins are patent bilaterally. 
Please see 
digitized image on PACS for formal sequential measurements. 

 
Brief Hospital Course:
___ year old female with PMH of IDDM c/b peripheral nephropathy 
and retinopathy s/p renal transplant in ___, HTN, who initially 
presented to ___ for infection on her left 
third toe x 1 week. Transferred to ___ given renal transplant 
history, for further evaluation by vascular surgery. She was 
transitioned to oral antibiotics with plan for follow-up labs 3 
days after discharge, angiogram as outpatient, continuation of 
antibiotics until follow-up with podiatry. 

ACUTE ISSUES 

# Left ___ Toe Foot Ulcer
# cellulitis 
# diabetic foot ulcer: Patient presented with left third toe 
necrosis and cellulitis
after traumatic injury (nail clipping). She had debridement and 
IV abx (vancomycin, ciprofloxacin, flagyl ___ at OSH with 
continued erythema and necrotic material. She had ABI that 
suggest multilevel PAD that will likely need re-vascularization. 
Foot exam was stable throughout hospital stay, she never met any 
SIRS or qSOFA criteria, no leukocytosis, CRP WNL, blood cultures 
were negative. She will undergo angiogram next week as 
outpatient. Until then she will continue on oral ciprofloxacin 
and Bactrim DS 1 tab BID. Her ultimate course should be 
determined after serial examination following potential 
revascularization on 
___. 

# Chest pain: Unclear etiology, appears to be longstanding per 
her report and
review of PCP notes in ___. EKGs unconcerning, stable, not 
typical pattern for angina and enzymes negative. Toponins were 
negative. Would consider additional outpatient evaluation. 

# Diabetic Nephropathy s/p Renal Transplant (___): continue 
home tacrolimus 1.5mg q12hrs (tacro trough: 4.6 on discharge) as 
well as home MMF.

CHRONIC ISSUES
# HTN/CAD: Cont metoprolol tartrate 50mg BID, losartan 25mg BID, 
consider decreasing metoprolol given bradycardia and increasing 
losartan given relatively HTN

# Cough/chronic sinusitis: Chronic cough in setting of recurrent 
sinusitis, bronchitis. Stable on admission. Continued home meds.

# Diabetes: Continued glargine and HISS with Humalog standing at 
meals. 

# Anxiety/bipolar disorder: Continued home lorazepam, 
nortriptyline, sertraline, lamotrigine.

# Osteoporosis: Continued calcium, vitamin D.

# Hypothyroid: Continued home levothyroxine. 

=============================
 TRANSITIONAL ISSUES
=============================
- discharge creat: 0.9 discharge K: 4.6
- discharge tacrolimus: 1.5mg q12hrs (tacro trough: 4.6)
- discharge weight: 72.39 kg
- FOLLOW-UP LABS: patient will have repeat electrolytes drawn on 
___ at ___, primary transplant nephrologist Dr. 
___ listed as attending
- will continue on ciprofloxacin and Bactrim for at least 2 
weeks s/p angiogram, ultimate duration per podiatry
- once off Bactrim would consider decreasing metoprolol given 
bradycardia and increasing losartan given relatively HTN but 
would have close follow-up of potassium levels
- she had atypical chest pain, which per her is longstanding 
issue and while may be related to anxiety may consider 
additional evaluation and/or PPI trial
- would follow with podiatrist in future for nail care
- she should have at least 500cc crystalloid pre and post 
contrast
#CODE: Full (presumed) 
#CONTACT: 
Name of health care proxy: ___
Relationship: husband
Phone number: ___
Cell phone: ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild 
2. Losartan Potassium 25 mg PO DAILY 
3. Calcium Carbonate 1000 mg PO DAILY 
4. Gabapentin 300 mg PO BID 
5. LamoTRIgine 200 mg PO DAILY 
6. LORazepam 2 mg PO QHS:PRN Anxiety 
7. LORazepam 1 mg PO BID: PRN anxiety 
8. Metoprolol Tartrate 50 mg PO BID 
9. Alendronate Sodium 70 mg PO QSUN 
10. Tretinoin 0.025% Cream 1 Appl TP QHS 
11. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
12. Creon 12 3 CAP PO TID W/MEALS 
13. GuaiFENesin ER 1200 mg PO Q12H 
14. Baclofen 10 mg PO TID: PRN Muscle Spasms 
15. Atorvastatin 80 mg PO QPM 
16. Mycophenolate Sodium ___ 360 mg PO BID 
17. Tacrolimus 1.5 mg PO Q12H 
18. Glargine 14 Units Bedtime
19. Aspirin 81 mg PO DAILY 
20. Levothyroxine Sodium 50 mcg PO DAILY 
21. Cyanocobalamin 1000 mcg IM/SC QMONTHLY 
22. Vitamin D 1000 UNIT PO DAILY 
23. Vitamin D ___ UNIT PO 2X/WEEK (MO,TH) 
24. estradiol 10 mcg vaginal twice weekly 
25. Cetirizine 10 mg PO DAILY 
26. Sertraline 150 mg PO DAILY 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve 
(12) hours Disp #*40 Tablet Refills:*0 
2.  Sulfameth/Trimethoprim DS 1 TAB PO BID 
RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by 
mouth twice a day Disp #*38 Tablet Refills:*0 
3.  Glargine 14 Units Bedtime 
4.  Acetaminophen ___ mg PO Q8H:PRN Pain - Mild  
5.  Alendronate Sodium 70 mg PO QSUN  
6.  Aspirin 81 mg PO DAILY  
7.  Atorvastatin 80 mg PO QPM  
8.  Baclofen 10 mg PO TID: PRN Muscle Spasms  
9.  Calcium Carbonate 1000 mg PO DAILY  
10.  Cetirizine 10 mg PO DAILY  
11.  Creon 12 3 CAP PO TID W/MEALS  
12.  Cyanocobalamin 1000 mcg IM/SC QMONTHLY  
13.  Estradiol 10 mcg vaginal TWICE WEEKLY  
14.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
15.  Gabapentin 300 mg PO BID  
16.  GuaiFENesin ER 1200 mg PO Q12H  
17.  LamoTRIgine 200 mg PO DAILY  
18.  Levothyroxine Sodium 50 mcg PO DAILY  
19.  LORazepam 2 mg PO QHS:PRN Anxiety  
20.  LORazepam 1 mg PO BID: PRN anxiety  
21.  Losartan Potassium 25 mg PO DAILY  
22.  Metoprolol Tartrate 50 mg PO BID  
23.  Mycophenolate Sodium ___ 360 mg PO BID  
24.  Sertraline 150 mg PO DAILY  
25.  Tacrolimus 1.5 mg PO Q12H  
26.  Tretinoin 0.025% Cream 1 Appl TP QHS  
27.  Vitamin D 1000 UNIT PO DAILY  
28.  Vitamin D ___ UNIT PO 2X/WEEK (MO,TH)  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
1) cellulitis (left ___ toe ulceration)

# Diabetic Nephropathy s/p Renal Transplant (___)
# Chest pain
# HTN
# Diabetes Mellitus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were transferred to ___ for further 
management of your foot infection and poor circulation in your 
legs.  You were evaluated by the kidney transplant team, 
vascular surgery, podiatry and infectious disease. 

The vascular surgery team will evaluate the blood vessels in 
your legs with an angiogram on ___. 

Now that you are going home:
- You are scheduled for a left lower extremity angiogram on 
___ 
- Continue to take all of your medications as prescribed 
including ciprofloxacin and Bactrim 
- As we discussed please come to ___ on ___ to have your 
labs checked, this is very important
- Do NOT stop taking your antibiotics until told to by your 
outpatient podiatrist
- The coordinator for vascular surgery should call you on ___ 
morning, if not please call ___ for further 
instructions regarding the procedure on ___

It was a pleasure taking care of you!

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-19 | hadm_id=23081631

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: UROLOGY
 
Allergies: 
Penicillins
 
Attending: ___.
 
Chief Complaint:
R ureteral stone
 
Major Surgical or Invasive Procedure:
R ureteroscopy/lithotripsy/stent placement

 
History of Present Illness:
HISTORY OF PRESENT ILLNESS:  Ms. ___ is a ___ female
with multiple medical problems including diabetes, chronic 
kidney
disease for which she will begin dialysis in ___ (baseline
creatinine 3.5-4.5 per patient, last Cr in OMR 3.3 ___, status
post gastric bypass two to ___ years prior, recently begun on
vitamin D replacement five months prior (___), who developed
acute onset of right-sided lower back pain with nausea and
vomiting on ___ evening (two days prior).  Since that time,
she has been able to take no medications and has minimal PO
intake.  She reports that she was nauseated all day yesterday 
but
was not vomiting.  She denies fever, chills. She describes the
pain as her right flank with radiation to her R upper abdomen 
and
labia.  She does not produce much urine, voiding twice daily and
twice nightly.

 
Past Medical History:
PMH:
hypertension, obesity, anemia, severe depression, anxiety, type 
2
diabetes mellitus, diverticulitis, lower GI bleed, gout,
hyperlipidemia, insomnia, and urinary tract infections.
PSH:
hysterectomy
gastric bypass 2 or ___ years ago
body contouring surgery.  She has
lumpectomy
vein stripping

MEDS: Last dose of all meds ___ night due to N/V.
ASA 325 HS 
Norvasc 10'
Advair PRN
Albuterol PRN
Calcitriol
Citalopram 40'
Crestor 40'
Flonase PRN
Fludrocortisone 0.1'
Lasix 40'
Lorazepam ___
Iron IV Qweek
Lantus 25 HS
Humalog SS

All: PCN

 
Social History:
___
Family History:
noncontributory
 
Physical Exam:
AVSS
Gen: NAD
Abd: soft, NT, ND

 
Pertinent Results:
___ 06:12AM BLOOD Glucose-63* UreaN-67* Creat-6.7* Na-140 
K-3.6 Cl-106 ___ AnGap-15
 
Brief Hospital Course:
The patient was admitted to Dr. ___ service from 
the ___ ED for pain control, and IV fluids.  In the morning 
she was takent to the OR for R ureteroscopy/laer lithotripsy/R 
ureteral stent placement.  There were no complications; please 
see dictated operartive note for full detail.  She was voiding 
without difficulty and did not have any pain upon arriving back 
ont he floor.  She was tolerating a regular diet.  At discharge, 
patient's pain well controlled with oral pain medications, 
tolerating regular diet, ambulating without assistance, and 
voiding without difficulty.  She is given explicit instructions 
to call Dr. ___.  She is scheduled to follow 
up with her renal doctors for ___ and preparationf 
or dialysis on ___.  She will contact them for a creatinine 
check early next week.
 
Discharge Medications:
1. Acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours).  
2. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

3. Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
4. Rosuvastatin 20 mg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
5. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) 
Spray Nasal DAILY (Daily).  
6. Fludrocortisone 0.1 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
7. Oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) 
hours as needed for pain.
Disp:*30 Tablet(s)* Refills:*0*
8. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: 
take this medication while you are taking oxycodone.
Disp:*60 Capsule(s)* Refills:*2*
9. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
R ureteral stone

 
Discharge Condition:
Stable

 
Discharge Instructions:
Discharge Instructions

-No vigorous physical activity for 2 weeks. 

-Expect to see occasional blood in your urine and to experience 
urgency and frequecy over the next month.

-You may have already passed your kidney stone, or it may still 
be in the process of passing.  You may experience some pain 
associated with spasm of your ureter.  This is normal.  Take 
Motrin as directed and take the narcotic pain medication as 
prescribed if additional pain relief is needed.   

-Tylenol should be your first line pain medication, a narcotic 
pain medication has been prescribed for breakthough pain >4.  
Replace Tylenol with narcotic pain medication.  Max daily 
Tylenol dose is 4gm, note that narcotic pain medication also 
contains Tylenol (acetaminophen)

-Make sure you drink plenty of fluids to help keep yourself 
hydrated and facilitate passage of stone fragments.

-You may shower and bathe normally. 

-Do not drive or drink alcohol while taking narcotics

-Colace has been prescribed to avoid post surgical constipation 
and constipation related to narcotic pain medication, 
discontinue if loose stool or diarrhea develops.

-Resume all of your home medications, unless otherwise noted.

-Call Dr. ___ for ___ AND if you have any 
questions. 

-Please make sure to call your renal doctor or primary care 
provider to have your creatinine checked by ___.

-If you have fevers > 101.5 F, vomiting, severe abdominal pain, 
or inability to urinate, call your doctor or go to the nearest 
emergency room.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-24 | hadm_id=23232542

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___
 
Chief Complaint:
Urinary tract infection
 
Major Surgical or Invasive Procedure:
___: Right Sided Midline Placed

 
History of Present Illness:
___ with history of Type II diabetes, ESRD s/p renal transplant 
in ___ and recurrent pulmonary infections presenting after 
recent diagnosis of UTI sensitive to IV antibiotics only.  
 Over the past 2 months, she has had increased suprapubic pain 
with burning on urination initially now chronically. She denies 
any recent fevers, chills, n/v or diarrhea. Has had back pain 
with her UTIs. She was treated last month with cefpodoxime 
however grew E coli at ___ in the setting of active 
treatment with cefpodoxime. She spoke to her nephrologist on 
___ who wanted her to drop a urine sample which ultimately grew 
E coli sensitive to ertapenem, meropenem, gentamicin and 
nitrofurantoin. Given that patient had UTI resistant to any PO 
antibiotics, she was referred in for evaluation.  
 Of note, the patient has a history of a chronic UTI as well as 
recurrent infections since her renal transplant. She was 
previously maintained on prophylactic Bactrim but has not been 
on Bactrim for over a year per patient. She has also recently 
started IVIG for immunoglobulin deficiencies, first dose 
approximately 3 weeks prior to admission.  
 In the ED, initial vitals were: 97.7 60 167/100 18 96%RA  
 Exam notable for: suprapubic tenderness and CVA tenderness 
bilaterally, kidney transplant in RLQ without tenderness to 
palpation. No edema in bilateral lower extremities.  
 Labs notable for: WBC 8.0 with 73% polys, Cr 1.0, total protein 
of 6.5. UA with 51 WBC, large leuks, nitrite positive and 30 
protein. Lactate 1.2. Blood and urine cultures sent.  
 Imaging notable for:  
 - Renal transplant ultrasound with mild-moderate hydronephrosis 
in transplant kidney, worse than seen on MRI for ___ with 
diffusely elevated resistive indices in the segmental and main 
renal arteries.  
 Patient was given Meropenem 500mg IV.  
 Transplant nephrology consulted and recommended continuing home 
meds, checking prograft level in AM and urine PCR as well as 
renal ultrasound and IV antibiotics.  
 Vitals prior to transfer: 98.2 56 189/83 18 99%RA  
 On the floor, patient confirms the above history. Reports she 
feels ok though has ongoing urinary frequency and urgency with 
dysuria. Denies fevers, chills.  

 
Past Medical History:
 Diabetes, insulin dependent, ? type I vs II  
 ESRD s/p Renal transplant in ___, baseline Cr  
 Hypertension  
 Hyperlipidemia  
 S/p gastric bypass  
 H/o GI bleed (lower, ___  
 Chronic cough, bronchiectasis s/p IVIG  
 Diabetic retinopathy  
 Anxiety/depression  
 Bipolar disorder  
 B12 deficiency  
 Gout  
 S/p TAH ___  
 Orthostatic hypotension  
 
Social History:
___
Family History:
No family history of diabetes or kidney disease  
 
Physical Exam:
ADMISSION EXAM
==================
Vital Signs: 97.8PO 181/66 R Sitting 58 18 100 RA  
 General: Alert, oriented, no acute distress  
 HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated  
 CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
 Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
 Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, Well healed incision on RLQ without ttp, mild 
CVA tenderness on exam  
 GU: No foley  
 Ext: Warm, well perfused, 2+ DP pulses, no edema  
 Neuro: Grossly intact  

DISCHARGE EXAM
==================
Vital Signs: T98.1 PO 145-159/56-65 HR58-65 O2 97/RA
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated  
CV: RRR nl s1/s2, no m/r/g
Pulm: CTAB
Abdomen: Soft, nt/nd, well-healed incision on RLQ c/d/i, mild 
bilateral CVA tenderness
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, Well healed incision on RLQ without ttp, 
previous CVA tenderness resolved
GU: No foley  
Ext: Warm, well perfused, 2+ DP pulses, no edema  
 
Pertinent Results:
ADMISSION LABS
==================
___ 07:20PM BLOOD WBC-8.1 RBC-4.76 Hgb-13.5 Hct-43.7 MCV-92 
MCH-28.4 MCHC-30.9* RDW-14.2 RDWSD-47.7* Plt ___
___ 07:20PM BLOOD Neuts-73.0* Lymphs-17.0* Monos-7.4 
Eos-1.9 Baso-0.5 Im ___ AbsNeut-5.91 AbsLymp-1.38 
AbsMono-0.60 AbsEos-0.15 AbsBaso-0.04
___ 07:20PM BLOOD Plt ___
___ 07:20PM BLOOD Glucose-330* UreaN-14 Creat-1.0 Na-139 
K-4.4 Cl-103 HCO3-25 AnGap-15
___ 07:20PM BLOOD TotProt-6.5
___ 03:30AM BLOOD tacroFK-15.6
___ 07:28PM BLOOD Lactate-1.2

___ 05:24PM URINE Blood-NEG Nitrite-POS Protein-30 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG
___ 05:24PM URINE RBC-2 WBC-51* Bacteri-MOD Yeast-NONE 
Epi-<1 TransE-<1
___ 05:24PM URINE Color-Straw Appear-Hazy Sp ___
___ 04:18PM URINE Hours-RANDOM Creat-31 TotProt-14 
Prot/Cr-0.5*

===================
DISCHARGE LABS
===================
___ 05:10AM BLOOD WBC-6.0 RBC-4.68 Hgb-13.4 Hct-41.8 MCV-89 
MCH-28.6 MCHC-32.1 RDW-14.4 RDWSD-46.5* Plt ___
___ 05:10AM BLOOD Plt ___
___ 05:10AM BLOOD Glucose-105* UreaN-15 Creat-1.0 Na-142 
K-4.7 Cl-107 HCO3-27 AnGap-13
___ 05:10AM BLOOD Calcium-8.8 Phos-4.0 Mg-2.0
___ 05:10AM BLOOD tacroFK-12.1

=====================
MICROBIOLOGY
=====================
Urine culture ___ - ESCHERICHIA COLI.    >100,000 ORGANISMS/ML.. 

Blood culture ___ x2 - NGTD
Blood culture ___ x2 - NGTD

======================
IMAGING
======================
Renal transplant ultrasound ___:
1. Mild to moderate hydronephrosis in the transplant kidney, 
seen on prior MRI 
from ___, but appears worse. 
2. Diffusely elevated resistive indices 
 
Brief Hospital Course:
Information for Outpatient Providers: ___ with history of Type 
II diabetes, ESRD s/p renal transplant in ___ and recurrent 
pulmonary infections presenting with MDR UTI.

# UTI: Patient with chronic colonization vs recurrent UTIs 
presented with continued suprapubic pain, urinary burning, and 
flank pain. Culture at outpatient nephrologist office on ___ 
showed Ecoli UTI sensitive only to meropenem, gentamicin, 
macrobid. Was started on IV meropenem upon admission. Infectious 
disease was consulted and sensitivities were sent for ertapenem 
given easier ability to dose medication. Per ID, recommended 
discharge on ertapenem with end date ___. Patient 
received a midline prior to discharge for intravenous 
antibiotics.

Patient was scheduled for Urology appointment to assess 
urodynamic studies to evaluate cause of recurrent urinary tract 
infections. She has follow up appointment with transplant 
infectious disease as well. 

# Renal transplant: s/p renal transplant in ___ on tacro and 
MMF. Renal ultrasound showed worsening hydronephrosis on imaging 
with elevated resistive indices, thought to be consistent with 
infection. Tacrolimus levels were drawn and were elevated at 
12.1. Her tacrolimus was decreased to 1.5 mg PO BID.

CHRONIC ISSUES:
#HTN: Continued metoprolol tartrate 50mg BID 
# Cough/chronic sinusitis: Chronic cough in setting of recurrent 
sinusitis, bronchitis. Stable on admission. Continued home 
medications.
# Diabetes: Continued glargine and HISS with Humalog standing at 
meals. Humalog was decreased to 6 mg at breakfast, 6 units at 
lunch, and 6 units at dinner. 
#Anxiety/bipolar disorder: Continued home lorazepam, 
nortriptyline, sertraline, lamotrigine.
#Osteoporosis: Continued alendronate, vitamin D.
#Hypothyroid: Continued home levothyroxine.

TRANSITIONAL ISSUES:
- Tacrolimus dose was changed from 2 mg PO BID to 1.5 mg PO BID. 

- Please obtain repeat tacrolimus level at next visit. 
- Please continue IV ertapenem with end date ___ per ID 
recommendations. 
- Please obtain a repeat ultrasound of the transplanted kidney 
after treatment of the urinary tract infection, given evidence 
of hydronephrosis.
- Patient will benefit from Urology consultation and follow-up 
to asses urodynamic studies.
- Please discuss need for Bactrim given immunosuppression and 
renal transplant. This can be assess with patient's transplant 
nephrologist. 
- Please discuss need for suppressive antibiotics given history 
of recurrent urinary tract infections. This should be discussed 
at patient's next transplant ID appointment with Dr. ___. 
- Patient noted to have systolic blood pressures 140s-150s 
during hospitalization. Please consider titration of 
anti-hypertensive regimen as an outpatient. 
- Consider MRI of abdomen if patient continues to experience 
flank pain/pain at site of the transplanted kidney. 
- Code Status: Full 
- Contact Information: Husband ___ ___  
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB 
2. Albuterol Inhaler ___ PUFF IH Q4H:PRN wheezing 
3. Alendronate Sodium 70 mg PO QSUN 
4. Atorvastatin 80 mg PO QPM 
5. Cetirizine 10 mg PO QHS 
6. Vitamin D 1000 UNIT PO DAILY 
7. Guaifenesin-Dextromethorphan 60/1200 mg PO BID:PRN cough 
8. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
9. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
10. LamoTRIgine 200 mg PO DAILY 
11. Glargine 16 Units Bedtime
Humalog 12 Units Breakfast
Humalog 12 Units Lunch
Humalog 12 Units Dinner
Insulin SC Sliding Scale using UNK Insulin
12. Levothyroxine Sodium 50 mcg PO DAILY 
13. LORazepam 2 mg PO QHS 
14. Metoprolol Tartrate 50 mg PO BID 
15. Mycophenolate Mofetil 500 mg PO BID 
16. Nortriptyline 50 mg PO QHS 
17. Sertraline 150 mg PO DAILY 
18. Tacrolimus 2 mg PO Q12H 
19. Cyanocobalamin 1000 mcg IM/SC MONTHLY 
20. LORazepam 1 mg PO BID:PRN anxiety 

 
Discharge Medications:
1. Ertapenem Sodium 1 g IV 1X Duration: 1 Dose 
RX *ertapenem [___] 1 gram 1 gram IV daily Disp #*11 Vial 
Refills:*0
RX *ertapenem [Invanz] 1 gram 1 gram IV daily Disp #*9 Vial 
Refills:*0
2. Glargine 16 Units Bedtime
Humalog 6 Units Breakfast
Humalog 6 Units Lunch
Humalog 6 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
3. LamoTRIgine 200 mg PO DAILY 
4. Levothyroxine Sodium 50 mcg PO DAILY 
5. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB 
6. Atorvastatin 80 mg PO QPM 
7. Cetirizine 10 mg PO QHS 
8. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
9. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID 
10. LORazepam 2 mg PO QHS 
11. Metoprolol Tartrate 50 mg PO BID 
12. Mycophenolate Mofetil 500 mg PO BID 
13. Nortriptyline 50 mg PO QHS 
14. Sertraline 150 mg PO DAILY 
15. Vitamin D 1000 UNIT PO DAILY 
16. Albuterol Inhaler ___ PUFF IH Q4H:PRN wheezing 
17. Alendronate Sodium 70 mg PO QSUN 
18. Cyanocobalamin 1000 mcg IM/SC MONTHLY 
19. Guaifenesin-Dextromethorphan 60/1200 mg PO BID:PRN cough 
20. LORazepam 1 mg PO BID:PRN anxiety 
21. Tacrolimus 1.5 mg PO Q12H 
22. Tacrolimus 0.5 mg PO Q12H 
RX *tacrolimus 0.5 mg 1 capsule(s) by mouth every twelve (12) 
hours Disp #*60 Capsule Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
=================
Primary Diagnosis
=================
-Multi-drug resistant urinary tract infection 

=================
Secondary diagnosis
===================
-s/p Kidney transplant
-Hypertension
-Hyperlipidemia
-Anxiety/Depression
-Type II Diabetes Mellitus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms ___,

You were transferred to ___ because you had a urinary tract 
infection (UTI) which was resistant to antibiotics by mouth. You 
were started on an IV antibiotic called ertapenem, and you were 
discharged with an IV line in place to continue getting your IV 
antibiotic. 

Please take note of the following:
- Please continue your intravenous ertapenem with end date ___. You received an additional prescription to get your IV 
antibiotics until ___. Initially it was scheduled until ___, but infectious disease's new recommendation is until ___. 
- Your tacrolimus level was decreased to 1.5 milligrams by mouth 
EVERY 12 HOURS. Please take 1.5 milligrams by mouth EVERY 12 
HOURS. 
- Your Humalog with meals was also decreased from 12 units with 
breakfast, 12 units with lunch, and 12 units with dinner, to 6 
units with breakfast, 6 units with lunch, and 6 units with 
dinner. 
- Please attempt to have scheduled urination every ___ hours 
rather than waiting until you have the urge to urinate. This can 
help reduce the number of urinary tract infections you may 
experience.
-Please discuss with your transplant nephrologist whether you 
need to be on Bactrim (trimethoprim-sulfamethoxazole). Please 
call your transplant nephrologist (Dr. ___ to discuss 
this).  

It was a pleasure taking care of you during your 
hospitalization! We wish you all the best!

Sincerely,
Your ___ Care Team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-27 | hadm_id=24263396

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Latex
 
Attending: ___.
 
Chief Complaint:
LEFT LEG CLAUDICATION
 
Major Surgical or Invasive Procedure:
Left lower extremity angiogram and superficial femoral artery 
stent angioplasty

 
History of Present Illness:
___ DM, ESRD s/p DDRT ___, baseline Cr currently 0.9-1.0) and 
PAD with prior LLE SFA stent for claudication (___) now 
presents for pre-admission hydration before a planned LLE 
angiogram for in-stent restenosis causing recurrent and 
progressive claudication symptoms in her left calf with walking.
 
Past Medical History:
PMH: PAD, DM1, ESRD s/p DDRT, pancreatic cysts, chronic 
abdominal
pain, chronic cough/bronchiectasis, hypogammablobulinemia s/p
IVIG, gastroparesis, peripheral neuropathy, diabetic
retinopathy/retinal detachment, recurrent PNA, HLD, HTN, gout,
orthostatic hypotension, bipolar disorder, anxiety/depression,
VitB12 deficiency, LGIB, venous varicosities

PSH: DDRT ___, RNYGB ___, vaginal hysterectomy (not for
malignancy), tonsillectomy, R knee surgery for patellar 
fracture,
cervical LN excisional Bx, temporal artery bx, ureteral
stent/cystoscopy, L SFA drug eluting stent (___)
 Diabetes, insulin dependent, ? type I vs II  
 ESRD s/p Renal transplant in ___, baseline Cr  
 Hypertension  
 Hyperlipidemia  
 S/p gastric bypass  
 H/o GI bleed (lower, ___  
 Chronic cough, bronchiectasis s/p IVIG  
 Diabetic retinopathy  
 Anxiety/depression  
 Bipolar disorder  
 B12 deficiency  
 Gout  
 S/p TAH ___  
 Orthostatic hypotension  
 
Social History:
___
Family History:
No family history of diabetes or kidney disease  
 
Physical Exam:
Vitals: 24 HR Data (last updated ___ @ 1202)
    Temp: 98.0 (Tm 98.3), BP: 161/76 (125-187/55-78), HR: 57
(56-65), RR: 16 (___), O2 sat: 94% (93-96), O2 delivery: Ra
GENERAL: [x]NAD  []A/O x 3  []intubated/sedated []abnormal
CV: [x]RRR  [] irregularly irregular []no MRG  []Nl S1S2
[]abnormal
PULM: []CTA b/l  [x]no respiratory distress  []abnormal
ABD: [x]soft  [x]Nontender  []appropriately tender 
[]nondistended  []no rebound/guarding  []abnormal
WOUND: R groin puncture site without ecchymosis or palpable
hematoma
 
Pertinent Results:
___ 05:25AM BLOOD Hct-40.1
___ 05:25AM BLOOD Creat-0.9 K-4.1
___ 03:59AM BLOOD WBC-7.7 RBC-4.83 Hgb-13.4 Hct-43.0 MCV-89 
MCH-27.7 MCHC-31.2* RDW-15.7* RDWSD-50.9* Plt ___
___ 03:59AM BLOOD Glucose-103* UreaN-17 Creat-1.0 Na-143 
K-4.7 Cl-102 HCO3-32 AnGap-9*
___ 03:59AM BLOOD Calcium-9.7 Phos-4.0 Mg-1.9
___ 03:59AM BLOOD ___ PTT-26.4 ___ DM, ESRD s/p DDRT ___, baseline Cr currently 0.9-1.0) and 
PAD with prior LLE
SFA stent for claudication (___) presents for pre-admission 
hydration before a planned LLE angiogram for in-stent restenosis 
causing recurrent and progressive claudication symptoms in her 
left calf with walking.  

The patient was taken to the endovascular suite and underwent 
angioplasty of the left SFA in stent stenosis. The patient 
tolerated the procedure well without complications and was 
brought to the post-anesthesia care unit in stable condition. 
After a brief stay, the patient was transferred to the vascular 
surgery floor where she remained through the rest of the 
hospitalization.  her home medication regimen for her chronic 
medical conditions was maintained throughout her 
hospitalization. 

Post-operatively, she did well without any groin swelling. She 
was able to tolerate a regular diet, get out of bed and ambulate 
without assistance, void without issues, and pain was controlled 
on oral medications alone.  She was deemed ready for discharge, 
and was given the appropriate discharge and follow-up 
instructions.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Estradiol 10 mcg vaginal TWICE WEEKLY 
2. Creon (lipase-protease-amylase) 24,000-76,000 -120,000 unit 
oral as directed 
3. Aspirin 81 mg PO DAILY 
4. Atorvastatin 80 mg PO QPM 
5. Baclofen 10 mg PO TID: PRN Muscle Spasms 
6. Cyanocobalamin 1000 mcg IM/SC QMONTHLY 
7. Gabapentin 300 mg PO TID 
8. LamoTRIgine 200 mg PO DAILY 
9. Levothyroxine Sodium 50 mcg PO DAILY 
10. LORazepam 2 mg PO QHS:PRN Anxiety 
11. LORazepam 1 mg PO BID: PRN anxiety 
12. Mycophenolate Sodium ___ 360 mg PO BID 
13. Sertraline 150 mg PO DAILY 
14. Tacrolimus 1.5 mg PO Q12H 
15. Tretinoin 0.025% Cream 1 Appl TP QHS 
16. Vitamin D ___ UNIT PO DAILY 
17. Clopidogrel 75 mg PO DAILY 
18. Metoprolol Tartrate 50 mg PO BID 
19. TraMADol 50 mg PO TID:PRN Pain - Moderate 
20. Glargine 14 Units Dinner
Insulin SC Sliding Scale using HUM Insulin

 
Discharge Medications:
1.  Glargine 14 Units Dinner
Insulin SC Sliding Scale using HUM Insulin 
2.  Aspirin 81 mg PO DAILY  
3.  Atorvastatin 80 mg PO QPM  
4.  Baclofen 10 mg PO TID: PRN Muscle Spasms  
5.  Clopidogrel 75 mg PO DAILY 
FOR THE NEXT ___ DAYS ONLY  
6.  Creon (lipase-protease-amylase) 24,000-76,000 -120,000 unit 
oral as directed  
7.  Cyanocobalamin 1000 mcg IM/SC QMONTHLY  
8.  Estradiol 10 mcg vaginal TWICE WEEKLY  
9.  Gabapentin 300 mg PO TID  
10.  LamoTRIgine 200 mg PO DAILY  
11.  Levothyroxine Sodium 50 mcg PO DAILY  
12.  LORazepam 2 mg PO QHS:PRN Anxiety  
13.  LORazepam 1 mg PO BID: PRN anxiety  
14.  Metoprolol Tartrate 50 mg PO BID  
15.  Mycophenolate Sodium ___ 360 mg PO BID  
16.  Sertraline 150 mg PO DAILY  
17.  Tacrolimus 1.5 mg PO Q12H  
18.  TraMADol 50 mg PO TID:PRN Pain - Moderate  
19.  Tretinoin 0.025% Cream 1 Appl TP QHS  
20.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Peripheral Arterial Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,
It was a pleasure taking care of you at ___ 
___.  You were admitted to the hospital after a 
peripheral angiogram. We admitted you to the hospital for IV 
hydration secondary to your kidney transplant.  To do the test, 
a small puncture was made in one of your arteries.  The puncture 
site heals on its own: there are no stitches to remove.   You 
tolerated the procedure well and are now ready to be discharged 
from the hospital.   Please follow the recommendations below to 
ensure a speedy and uneventful recovery.

Peripheral Angiography
Puncture Site Care
For one week:
Do not take a tub bath, go swimming or use a Jacuzzi or hot 
tub.
Use only mild soap and water to gently clean the area around 
the puncture site. 
Gently pat the puncture site dry after showering. 
Do not use powders, lotions, or ointments in the area of the 
puncture site. 

You may remove the bandage and shower the day after the 
procedure.  You may leave the bandage off. 
You may have a small bruise around the puncture site.  This is 
normal and will go away one-two weeks. 

Activity 
For the first 48 hours: 
Do not drive for 48 hours after the procedure
For the first week:
Do not lift, push , pull or carry anything heavier than 10 
pounds
Do not do any exercises or activity that causes you to hold 
your breath or bear down with abdominal muscles.   Take care not 
to put strain on your abdominal muscles when coughing, sneezing, 
or moving your bowels.

After one week:
You may go back to all your regular activities, including 
sexual activity.  We suggest you begin your exercise program at 
half of your usual routine for the first few days.   You may 
then gradually work back to your full routine.
Medications:
Before you leave the hospital, you will be given a list of all 
the medicine you should take at home.  If a medication that you 
normally take is not on the list or a medication that you do not 
take is on the list please discuss it with the team!  

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-26 | hadm_id=25573237

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___
 
Chief Complaint:
cellulitis
 
Major Surgical or Invasive Procedure:
___ LLE angiogram, L SFA drug eluting stent 

 
History of Present Illness:
___ year old female with PMH of IDDM c/b peripheral nephropathy 
and retinopathy s/p renal transplant in ___, HTN, with recent 
admission for left toe foot ulcer s/p debridement (discharged on 
___, now presenting with toe pain/rash, admitted for 
cellulitis. 

During recent hospitalization she was treated with IV 
antibiotics and had serial debridements, discharged on ___ 
for the weekend on PO cipro with plan for angiogram on 
___. 
She presented to clinic on day of admission with worsening LLE 
swelling, redness, mild pain, up to her shin. No fevers, cough, 
ST, rhinorrhea, abdominal pain, dysuria, frequency, leg 
swelling, rhinorrhea, CP, SOB.

In the ED initial vitals:  97.4 54 138/45 18 100% RA 

- Exam notable for:  
LLE wwp bilateral circumferential edema and erythema to the 
lower knee, DP palpated, 1cm ulcer with clean margins to base of 
third toe, third toe erythema and edema

- Labs notable for:
CBC: WC 7.8, hgb 13.1, plt 168
Chem7: Na 143, K 5.0, Cl 108, bicarb 22, BUN 18, Cr 1.3
lactate 3.0
UA WNL

- Consults: vascular surgery, transplant nephrology 

- Patient was given: vancomycin, flagyl   

Upon arrival to the floor, the redness in her foot improved 
significantly with one dose of vancomycin and flagyl, and now 
the erythema is only over her ___ digit but does not extend 
beyond that.

 
Past Medical History:
 Diabetes, insulin dependent, ? type I vs II  
 ESRD s/p Renal transplant in ___, baseline Cr  
 Hypertension  
 Hyperlipidemia  
 S/p gastric bypass  
 H/o GI bleed (lower, ___  
 Chronic cough, bronchiectasis s/p IVIG  
 Diabetic retinopathy  
 Anxiety/depression  
 Bipolar disorder  
 B12 deficiency  
 Gout  
 S/p TAH ___  
 Orthostatic hypotension  
 
Social History:
___
Family History:
No family history of diabetes or kidney disease  
 
Physical Exam:
ADMISSION EXAM
=============================
VS:97.5 179/66 65 18 96 RA 
GENERAL: well developed, well nourished in NAD 
HEENT: sclera anicteric, MMM
CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops
LUNGS: CTABL, no wheezes, rales, or rhonchi, normal WOB 
ABDOMEN: soft, non-tender, non-distended
EXTREMITIES: warm, cap refill <2 sec in bilateral ___ toes,
unable to palpate DPs or R TP, L TP 1+, L ___ toe w 1cmx1cm
dry, necrotic ulcer w surround erythema  
NEURO: AOx3, face symmetric, moving all extremities with purpose

DISCHARGE EXAM
=============================
VITALS: Temp: 98.5 (Tm 98.6), BP: 115/66 (115-171/48-73), HR: 70
(55-76), RR: 20 (___), O2 sat: 96% (92-96), O2 delivery: RA 
GENERAL: well developed, well nourished in NAD 
HEENT: sclera anicteric, MMM
CARDIAC: regular rate and rhythm, no murmurs, rubs, or gallops
LUNGS: CTABL, no wheezes, rales, or rhonchi, normal WOB
ABDOMEN: soft, non-tender, non-distended
EXTREMITIES: warm, cap refill <2 sec in bilateral ___ toes,
both ___ palpable bilaterally, L ___ toe w 1cmx1cm dry,
necrotic ulcer w surround erythema, no edema, R groin access 
site
w small amt dried blood on dressing, no bruits, induration, or
bruising, L inner thigh mildly TTP without bruising 
NEURO: AOx3, face symmetric, moving all extremities with purpose
 
Pertinent Results:
ADMISSION LABS
===================================
___ 02:09PM   LACTATE-3.0*
___ 01:50PM   GLUCOSE-191* UREA N-18 CREAT-1.3* SODIUM-143 
POTASSIUM-5.0 CHLORIDE-108 TOTAL CO2-22 ANION GAP-13
___ 01:50PM   WBC-7.8 RBC-4.45 HGB-13.1 HCT-41.2 MCV-93 
MCH-29.4 MCHC-31.8* RDW-14.8 RDWSD-50.8*
___ 01:50PM   NEUTS-71.2* LYMPHS-16.7* MONOS-9.8 EOS-1.5 
BASOS-0.5 IM ___ AbsNeut-5.53 AbsLymp-1.30 AbsMono-0.76 
AbsEos-0.12 AbsBaso-0.04
___ 01:50PM   PLT COUNT-168
___ 11:20AM   GLUCOSE-130*
___ 11:20AM   UREA N-17 CREAT-1.1 SODIUM-144 POTASSIUM-5.1 
CHLORIDE-104 TOTAL CO2-20* ANION GAP-20*
___ 11:20AM   ALT(SGPT)-33 AST(SGOT)-29 ALK PHOS-94 TOT 
BILI-0.5
___ 11:20AM   ALBUMIN-4.3 CALCIUM-8.9 PHOSPHATE-4.2 
MAGNESIUM-2.0
___ 11:20AM URINE  HOURS-RANDOM CREAT-61 TOT PROT-17 
PROT/CREA-0.3*
___ 11:20AM   WBC-8.0 RBC-4.56 HGB-13.3 HCT-42.8 MCV-94 
MCH-29.2 MCHC-31.1* RDW-15.2 RDWSD-52.1*
___ 11:20AM   PLT COUNT-185
___ 11:20AM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 11:20AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 11:20AM URINE  RBC-0 WBC-<1 BACTERIA-NONE YEAST-NONE 
EPI-<1

INTERVAL LABS
===================================
___ 04:46AM BLOOD tacroFK-5.6
___ 04:47AM BLOOD tacroFK-5.9
___ 04:37AM BLOOD tacroFK-5.9
___ 11:20AM BLOOD tacroFK-5.1

DISCHARGE LABS
===================================
___ 04:46AM BLOOD WBC-6.7 RBC-3.86* Hgb-11.3 Hct-35.8 
MCV-93 MCH-29.3 MCHC-31.6* RDW-14.9 RDWSD-50.4* Plt ___
___ 04:46AM BLOOD Glucose-102* UreaN-11 Creat-0.9 Na-145 
K-4.2 Cl-112* HCO3-21* AnGap-12
___ 04:37AM BLOOD ALT-24 AST-20 LD(LDH)-142 AlkPhos-75 
TotBili-0.3
___ 04:46AM BLOOD Calcium-8.3* Phos-3.1 Mg-1.8

IMAGING
===================================
___ FOOT AP,LAT & OBL LEFT
AP, lateral and oblique views of the left foot were provided. In 
this patient with reported third toe ulceration, there is no 
evidence of bone destruction to suggest osteomyelitis. The bones 
appear slightly demineralized diffusely. No fracture or 
dislocation is seen.  Prominent heel spurs are noted. There is 
vascular calcification. 

___ ANGIOCATH REPORT 
pending at time of discharge, final report pending in ___ by Dr. 
___

MICRO
===================================
BLOOD CULTURE X2 NO GROWTH TO DATE, FINAL PENDING AND TIME OF 
DISCHARGE

 
Brief Hospital Course:
================
PATIENT SUMMARY:
================
___ year old female with PMH of IDDM c/b peripheral nephropathy 
and retinopathy s/p renal transplant in ___, HTN, with recent 
admission for left toe foot ulcer s/p debridement (discharged on 
___, now presenting with toe pain/rash, admitted for 
cellulitis. 

==============
ACUTE ISSUES:
==============
# Left third toe cellulitis in the setting of PVD. She was 
placed back on IV antibiotics on admission with improvement in 
cellulitis. ID, Podiatry and Vascular surgery were involved. She 
underwent left SFA angiogram and stent placement on ___ with 
improved left lower extremity blood flow. Podiatry performed a 
bedside debridement of the left toe ulcer with good bleeding 
response. No cultures were taken. Her antibiotics were 
transitioned from IV to PO, and she was discharged to complete 2 
weeks of treatment with Ciprofloxacin and Doxycycline with 
podiatry and vascular surgery follow up for continued wound 
assessment. 

# ___
# ESRD secondary to diabetic nephropathy s/p renal transplant 
___. Cr baseline of 1.0. She presented with Cr 1.3, likely 
pre-renal and in the setting of infection. Her Cr improved to 
baseline 0.9 on the day of discharge. She will have labs 
rechecked on ___ to monitor renal function and 
immunosuppressive dosing. 

# Immunosuppression. She was continued on Tacrolimus 1.5 mg bid 
and Myfortic 360 mg bid. 

# HTN/CAD: Her home metoprolol was discontinued secondary to 
bradycardia and her home losartan was held in the setting of 
___. She was started on amlodipine with instructions to continue 
holding losartan at the time of discharge until directed to 
restart by Dr. ___. 

====================
CHRONIC ISSUES:
====================
# Cough/chronic sinusitis: Continued home meds. 
# Diabetes: Continued glargine and HISS with novolog standing at 
meals. 
# Anxiety/bipolar disorder: Continued home lorazepam, 
nortriptyline, sertraline, lamotrigine.
# Osteoporosis: Continued calcium, vitamin D.
# Hypothyroid: Continued home levothyroxine. 
# Chronic hypogammaglobulinemia. Received IVIG as an outpatient 

====================
TRANSITIONAL ISSUES:
====================
- New Meds
-- Amlodipine 5mg 
-- Plavix 75mg (to be continued for 3 months)
-- Doxycycline 100mg BID 

- Stopped Meds 
-- Metoprolol 

- Held Meds
-- Losartan to be held until directed to restart by Dr. 
___ after labs on ___ to trend Cr 

- Patient to check blood pressure every day and call Dr. 
___ if SBP >160 
- Follow up with podiatry and vascular surgery as scheduled to 
monitor left ulcer
- All nail care to be done by podiatry in the future, not by 
patient
- During prior hospitalization (between this hospitalization and 
prior she was unable to attend any follow-up appointments bc of 
short interval) she had atypical chest pain, which per her is 
longstanding issue and while may be related to anxiety may 
consider additional evaluation and/or PPI trial
- Continue antibiotics (Ciprofloxacin and Doxycycline) for 2 
weeks until ___ then stop 
- Post-Discharge Follow-up Labs Needed: Chem 10 and tacrolimus 
level drawn on ___ with results sent to Dr. ___ 
- ___ weight: 73.12 kgs 161.2 lbs 
- Discharge creatinine: Cr. 0.9
- Tacrolimus 1.5mg BID, trough on day of discharge 5.6

#CODE: Full (presumed) 
#CONTACT: ___
Relationship: husband
Phone number: ___
Cell phone: ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 80 mg PO QPM 
4. Baclofen 10 mg PO TID: PRN Muscle Spasms 
5. Calcium Carbonate 1000 mg PO DAILY 
6. Cetirizine 10 mg PO DAILY 
7. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
8. Gabapentin 300 mg PO BID 
9. GuaiFENesin ER 1200 mg PO Q12H 
10. LamoTRIgine 200 mg PO DAILY 
11. Levothyroxine Sodium 50 mcg PO DAILY 
12. LORazepam 2 mg PO QHS:PRN Anxiety 
13. LORazepam 1 mg PO BID: PRN anxiety 
14. Losartan Potassium 25 mg PO DAILY 
15. Metoprolol Tartrate 50 mg PO BID 
16. Mycophenolate Sodium ___ 360 mg PO BID 
17. Sertraline 150 mg PO DAILY 
18. Tacrolimus 1.5 mg PO Q12H 
19. Vitamin D 1000 UNIT PO DAILY 
20. Alendronate Sodium 70 mg PO QSUN 
21. Cyanocobalamin 1000 mcg IM/SC QMONTHLY 
22. Estradiol 10 mcg vaginal TWICE WEEKLY 
23. Tretinoin 0.025% Cream 1 Appl TP QHS 
24. Vitamin D ___ UNIT PO 2X/WEEK (MO,TH) 
25. Ciprofloxacin HCl 500 mg PO Q12H 
26. Sulfameth/Trimethoprim DS 1 TAB PO BID 
27. Unknown Unknown Dose
Insulin SC Sliding Scale using UNK Insulin
28. Creon (lipase-protease-amylase) 24,000-76,000 -120,000 unit 
oral QIDACHS 

 
Discharge Medications:
1.  amLODIPine 5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Clopidogrel 75 mg PO DAILY 
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*90 
Tablet Refills:*0 
3.  Doxycycline Hyclate 100 mg PO Q12H 
Continue taking until ___ 
RX *doxycycline hyclate 100 mg 1 tablet(s) by mouth twice daily 
Disp #*28 Tablet Refills:*0 
4.  Glargine 14 Units Bedtime
Humalog 8 Units Breakfast
Humalog 8 Units Lunch
Humalog 8 Units Dinner
Insulin SC Sliding Scale using novolog Insulin 
5.  Acetaminophen ___ mg PO Q8H:PRN Pain - Mild  
6.  Alendronate Sodium 70 mg PO QSUN  
7.  Aspirin 81 mg PO DAILY  
8.  Atorvastatin 80 mg PO QPM  
9.  Baclofen 10 mg PO TID: PRN Muscle Spasms  
10.  Calcium Carbonate 1000 mg PO DAILY  
11.  Cetirizine 10 mg PO DAILY  
12.  Ciprofloxacin HCl 500 mg PO Q12H 
Continue taking until ___ 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice daily 
Disp #*28 Tablet Refills:*0 
13.  Creon (lipase-protease-amylase) 24,000-76,000 -120,000 unit 
oral QIDACHS  
14.  Cyanocobalamin 1000 mcg IM/SC QMONTHLY  
15.  Estradiol 10 mcg vaginal TWICE WEEKLY  
16.  Fluticasone Propionate NASAL 2 SPRY NU DAILY  
17.  Gabapentin 300 mg PO BID  
18.  GuaiFENesin ER 1200 mg PO Q12H  
19.  LamoTRIgine 200 mg PO DAILY  
20.  Levothyroxine Sodium 50 mcg PO DAILY  
21.  LORazepam 2 mg PO QHS:PRN Anxiety  
22.  LORazepam 1 mg PO BID: PRN anxiety  
23.  Mycophenolate Sodium ___ 360 mg PO BID  
24.  Sertraline 150 mg PO DAILY  
25.  Tacrolimus 1.5 mg PO Q12H  
26.  Tretinoin 0.025% Cream 1 Appl TP QHS  
27.  Vitamin D 1000 UNIT PO DAILY  
28.  Vitamin D ___ UNIT PO 2X/WEEK (MO,TH)  
29. HELD- Losartan Potassium 25 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until directed to 
restart by Dr. ___
30.Outpatient Lab Work
ICD10: Z94.0
Please collected Chem 10 and Tacrolimus level on ___ and fax 
results to ___ attn: Dr. ___

 
___ Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
====================
Cellulitis
Peripheral Vascular Disease
Acute Kidney Injury

SECONDARY DIAGNOSIS
====================
End stage renal disease
Renal transplant 
Type II Diabetes
Hypothyroidism
Bipolar Disorder

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,
   
You came to ___ because you had a skin infection on your toe. 
Please see more details listed below about what happened while 
you were in the hospital and your instructions for what to do 
after leaving the hospital.  
It was a pleasure participating in your care. We wish you the 
best!  

Sincerely,  
Your ___ Care Team  

WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL:  
- Your skin infection was treated with antibiotics.
- Vascular surgery performed an angiogram and placed a stent in 
an artery in your left leg. This improved the blood flow to your 
left foot.  
- You improved considerably and were ready to leave the hospital 
 
- You were seen by the Podiatry doctors who ___ your wound 
and the infection doctors who recommended the oral antibiotics. 

WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL:  
- Please follow up with your primary care doctor and other 
health care providers (see below)  
- Please take all of your medications as prescribed (see below). 
 
- Seek medical attention if you have pain, skin redness, fever, 
chills, or other symptoms of concern. 

***********

- Please check you blood pressure every day and record the 
values. If the top value (systolic blood pressure) is greater 
than 160, please call Dr. ___ for further 
instructions 
- Please continue to take your antibiotics for 2 weeks until 
___
- Please have your labs checked on ___ with results 
sent to Dr. ___ 

***********

Lower Extremity Angioplasty/Stent Discharge Instructions

MEDICATION:
 Take Aspirin 81mg once daily 
 As instructed, take Plavix (Clopidogrel) 75mg once daily for 3 
months then discuss with your vascular surgeon about continuing 
 Continue all other medications you were taking before surgery, 
unless otherwise directed
 You make take Tylenol or prescribed pain medications for any 
post procedure pain or discomfort

WHAT TO EXPECT:
 It is normal to have slight swelling of the legs:
 Elevate your leg above the level of your heart with pillows 
every ___ hours throughout the day and night
 Avoid prolonged periods of standing or sitting without your 
legs elevated
 It is normal to feel tired and have a decreased appetite, your 
appetite will return with time 
 Drink plenty of fluids and eat small frequent meals
 It is important to eat nutritious food options (high fiber, 
lean meats, vegetables/fruits, low fat, low cholesterol) to 
maintain your strength and assist in wound healing
 To avoid constipation: eat a high fiber diet and use stool 
softener while taking pain medication

ACTIVITIES:
 When you go home, you may walk and use stairs
 You may shower (let the soapy water run over groin incision, 
rinse and pat dry)
 Your incision may be left uncovered, unless you have small 
amounts of drainage from the wound, then place a dry dressing or 
band aid over the area 
 No heavy lifting, pushing or pulling (greater than 5 lbs) for 
1 week (to allow groin puncture to heal)
 After 1 week, you may resume sexual activity
 After 1 week, gradually increase your activities and distance 
walked as you can tolerate
 No driving until you are no longer taking pain medications 

CALL THE OFFICE FOR: ___
 Numbness, coldness or pain in lower extremities 
 Temperature greater than 101.5F for 24 hours
 New or increased drainage from incision or white, yellow or 
green drainage from incisions
 Bleeding from groin puncture site

SUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)
 Lie down, keep leg straight and have someone apply firm 
pressure to area for 10 minutes. If bleeding stops, call 
vascular office ___. If bleeding does not stop, call 
___ for transfer to closest Emergency Room.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13874311-DS-21 | hadm_id=26532706

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Latex
 
Attending: ___.
 
Chief Complaint:
Orthostatic hypotension
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 ___ yo F with ESRD on PD, T2DM, peripheral neuropathy, autonomic 
neuropathy and orthostatic hypotension who presents from her 
PCP's office with orthostatic hypotension. She reports recent 
decreased PO intake and diarrhea over the last 7 days. 
Additionally, she reports SOB and lower extremity fatigue with 
exertion, worse over the last 3 months. She went to her PCP's 
office this morning, where she was found to have supine BP of 
136/58, and SBP upon sitting of 70. Additionally, she reports 
that during this episode of hypotension, her feet were 
trembling, and she felt lightheaded. She was sent from the PCP's 
office to the ED for additional evaluation. 

In the ED, initial vitals were: T 99.8F, HR 110, BP 112/54, RR 
16, O2 Sat 99% RA. While in the ED she received 150 mL of NS 
IVF.

 
Past Medical History:
MEDICAL HISTORY:
--Hypertension
--Obesity
--Anemia
--Severe depression
--Anxiety
--Type 2 DM complicated by nephropathy leading to end-stage 
renal disease and initiation of peritoneal dialysis on ___. 
--Diverticulitis
--Lower GI bleed
--Gout
--Hyperlipidemia
--Insomnia
--Urinary tract infections   
.  
SURGICAL HISTORY:
--s/p hysterectomy  
--s/p gastric bypass 2 or ___ years ago  
--s/p lumpectomy  
--s/p vein stripping 
 
Social History:
___
Family History:
Her mother died at the age of ___- had h/o MI and died of sepsis. 
 Her father died at the age of ___ from stroke.  There is no 
significant family history of cancers. 

 
Physical Exam:
ON ADMISSION: 

VS -  T 98.2, HR 88, BP 117/50, RR 16, O2 Sat 100% RA
GENERAL - Comfortable appearing elderly female in NAD
HEENT - NC/AT, EOMI, sclerae anicteric, MMM 
LUNGS - CTAB
HEART - RRR, normal S1-S2, no m/r/g
ABDOMEN - NABS, soft/NT/ND, peritoneal catheter in place in the 
LLQ. Bandage overlying the catheter entry site that is c/d/i.
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (DPs). Left 
lower extremity has more bulk than right.  
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout.
 
 
Pertinent Results:
Admission:
___ 01:20PM BLOOD WBC-12.4* RBC-3.28* Hgb-9.8* Hct-30.1* 
MCV-92 MCH-30.0 MCHC-32.7 RDW-13.5 Plt ___
___ 01:20PM BLOOD Neuts-85.0* Lymphs-7.3* Monos-5.8 Eos-1.4 
Baso-0.5
___ 01:20PM BLOOD ___ PTT-26.5 ___
___ 01:20PM BLOOD Glucose-192* UreaN-47* Creat-11.4*# 
Na-135 K-3.6 Cl-93* HCO3-24 AnGap-22*
___ 01:20PM BLOOD ALT-23 AST-25 AlkPhos-78 TotBili-0.1
___ 01:20PM BLOOD cTropnT-0.04* proBNP-3211*
___ 01:20PM BLOOD Albumin-2.9* Calcium-8.1* Phos-9.1*# 
Mg-2.3
___ 07:10AM BLOOD TSH-3.7
___ 01:32PM BLOOD Lactate-1.4

Discharge:
___ 06:05AM BLOOD WBC-10.2 RBC-2.80* Hgb-8.3* Hct-25.4* 
MCV-91 MCH-29.5 MCHC-32.5 RDW-13.6 Plt ___
___ 06:05AM BLOOD Glucose-85 UreaN-46* Creat-8.5* Na-140 
K-3.6 Cl-104 HCO3-24 AnGap-16
___ 06:05AM BLOOD Calcium-7.8* Phos-4.6* Mg-2.0CXR 
___:  No acute cardiopulmonary process

___ Stim:
___ 05:40AM BLOOD Cortsol-12.2
___ 06:55AM BLOOD Cortsol-35.5*
___ 07:10AM BLOOD Cortsol-29.2*

Studies:
CXR (___)
PA and lateral radiographs of the chest show no evidence of 
consolidation or pneumonia.  There is no pleural effusion or 
pneumothorax.  The cardiomediastinal silhouette is normal.  
Multiple air filled loops of bowel are noted in the left upper 
quadrant.
 
Brief Hospital Course:
___ yo F with ESRD on PD, T2DM, peripheral neuropathy, autonomic 
neuropathy and orthostatic hypotension who presents from her 
PCP's office with orthostatic hypotension.

# Orthostatic hypotension: Improved in the setting of IVF 
rehydration and initiation of midodrine, fludrocortisone, and 
salt tabs. Likely secondary to a combination of autonomic 
dysfunction secondary to diabetes and dehydration secondary to 
decreased PO intake and recent diarrhea. PCP has raised concerns 
for anorexia, which could also contribute to her orthostatic 
hypotension. Another possible cause of hypotension is infection, 
although she has been afebrile, and has no localizing signs of 
infection. ___ test was within normal limits. 

# Troponinemia: No evidence of ischemia on EKG, and the patient 
was chest pain free. It is very difficult to interpret this lab 
value given the patient's renal function. However, there is 
little in her clinical picture to suggest that she has cardiac 
ischemia. 

# End-stage renal disease: Maintained on peritoneal dialysis, 
per renal recommendations. 

# Type 2 diabetes: Tightly controlled on this admission. She was 
maintained on her home insulin regimen. 

# Anemia: Crit was elevated on presentation, likely secondary to 
hemoconcentration. Work-up in the past has revealed anemia 
secondary end-stage renal disease and B12 deficiency. Per renal 
recommendations, she was given a split dose of epogen (4000 
units SC QMOWEFR). She was restarted on her home regimen of 
epogen upon discharge.

# Hyperlipidemia: Stable. She was maintained on her home dose of 
rosuvastatin.

# Anxiety: No active issues. She was maintained on her home dose 
of lorazepam.

 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from PatientPharmacywebOMR.
1. Lorazepam 2 mg PO HS anxiety 
Please hold for sedation 
2. Lorazepam 1 mg PO BID:PRN anxiety 
3. Polyethylene Glycol 17 g PO QHS 
4. Cyclobenzaprine 5 mg PO HS:PRN back spasm 
___ Tablet(s) by mouth QHS as needed for back pain or spasm  
5. Rosuvastatin Calcium 40 mg PO DAILY 
6. Glargine 25 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
7. Hydrocodone-Acetaminophen (5mg-500mg 1 TAB PO Q6H:PRN back 
pain 
8. Sertraline 100 mg PO DAILY 
9. Calcium Acetate ___ mg PO TID W/MEALS 
10. Mupirocin Cream 2% 1 Appl TP DAILY 
Apply to PD catheter exit site once daily 
11. ZYRtec *NF* 5 mg Oral daily 
12. melatonin *NF* 3 mg Oral QHS 
13. Epoetin Alfa 10,000 units SC WEEKLY Start: HS 

 
Discharge Medications:
1. Calcium Acetate ___ mg PO TID W/MEALS 
2. Cyclobenzaprine 5 mg PO HS:PRN back spasm 
___ Tablet(s) by mouth QHS as needed for back pain or spasm  
3. Epoetin Alfa 10,000 units SC WEEKLY 
4. Glargine 25 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
5. Lorazepam 2 mg PO HS anxiety 
Please hold for sedation 
6. Lorazepam 1 mg PO BID:PRN anxiety 
7. Mupirocin Cream 2% 1 Appl TP DAILY 
Apply to PD catheter exit site once daily 
8. Polyethylene Glycol 17 g PO QHS 
9. Rosuvastatin Calcium 40 mg PO DAILY 
10. Sertraline 100 mg PO DAILY 
11. melatonin *NF* 3 mg Oral QHS 
12. ZYRtec *NF* 5 mg Oral daily 
13. Fluconazole 200 mg PO Q24H 
14. Midodrine 10 mg PO TID 
RX *midodrine 10 mg 1 Tablet(s) by mouth three times a day Disp 
#*90 Tablet Refills:*2
15. Nephrocaps 1 CAP PO DAILY 
RX *Nephrocaps 1 mg 1 Capsule(s) by mouth daily Disp #*1 Capsule 
Refills:*2
16. Fludrocortisone Acetate 0.1 mg PO DAILY 
RX *fludrocortisone 0.1 mg 1 Tablet(s) by mouth daily Disp #*30 
Tablet Refills:*2
17. Sodium Chloride 1 gm PO BID orthostatic hypotension 
RX *sodium chloride 1 gram 1 Tablet(s) by mouth twice a day Disp 
#*60 Capsule Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:   Orthostatic hypotension

Secondary: End Stage Renal Disease
           Type 2 Diabetes Mellitus
           Anemia
           Hyperlipidemia
           Anxiety

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear ___, 

___ were admitted to the hospital after being found to have 
orthostatic hypotension (a drop in your blood pressure when 
standing) at your PCP's office. The most likely cause of this 
change in your blood pressure is a combination of dehydration 
and autonomic nerve dysfunction secondary to your diabetes. 
While ___ were in the hospital, ___ were given IV fluid 
rehydration and ___ were started on a few medications for 
additional long-term blood pressure support. With these 
interventions, your blood pressure normalized, and ___ improved. 


Additionally, while ___ were hospitalized ___ underwent a test 
to examine the function of your adrenal glands. This test, 
called a Cosyntropin-Stimulation Test, showed that ___ have 
normal adrenal gland function.

It was a pleasure taking care of ___. 

Please note that the following change has been made to your home 
medications:
1. Please start taking midodrine 10 mg by mouth three times per 
day.
2. Please start taking Salt Tabs (NaCl) 1 g by mouth three times 
per day.
3. Please start taking Fludrocortisone 0.1 mg by mouth daily
 
Followup Instructions:
___
